DNAJB8

UniProt ID: Q8NHS0
Organism: Homo sapiens
Review Status: IN PROGRESS
📝 Provide Detailed Feedback

Gene Description

DNAJB8 is a class B J-domain protein (Hsp40/DNAJ family, subfamily B) that functions as a potent holdase chaperone suppressing polyglutamine and other aggregation-prone protein aggregation. Its domain architecture comprises an N-terminal J-domain (JD), a G/F-rich region, an S/T-rich region containing the key 147-AFSSFN-152 steric-zipper oligomerization motif, and a C-terminal domain (CTD). A key regulatory mechanism is an intramolecular JD-CTD interaction that can sequester the JD surface and control Hsp70 recruitment as a reversible switch (DOI:10.1038/s41467-021-21147-x). Unlike canonical DNAJ co-chaperones that assist Hsp70-mediated protein refolding, DNAJB8 acts primarily as a holdase, with anti-aggregation activity largely independent of the J-domain residing in the C-terminal serine-rich (SSF-SST) region and C-terminal tail (PMID:20159555). DNAJB8 self-assembles into oligomeric puncta via the AFSSFN steric-zipper motif (resolved at 0.75 angstrom by MicroED, class 6 steric zipper), but engineered monomeric variants retain substrate binding and anti-aggregation function, demonstrating that oligomerization is mechanistically separable from chaperone activity (DOI:10.1016/j.str.2024.02.015). DNAJB8 uses distinct substrate-binding modes: a serine-rich stretch for fibrillar/amyloid aggregation suppression and a separate CTD TTK-LKS motif for amorphous inclusion suppression via Hsp70-dependent proteasomal degradation (DOI:10.1242/jcs.255596). DNAJB8 is also a cancer-testis antigen preferentially expressed in renal and colorectal cancer stem-like cells, controlling tumor-initiating capacity (DOI:10.1158/0008-5472.CAN-11-3062), and promotes oxaliplatin chemoresistance in colon cancer via TP53 stabilization leading to MDR1/P-gp upregulation (DOI:10.1038/s41419-022-04599-x). DNAJB8 is enriched in testis but expressed in multiple tissues, and localizes to both cytosol and nucleus.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005737 cytoplasm
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for cytoplasm localization is well supported. DNAJB8 is a cytoplasmic J-domain co-chaperone. Hageman et al. (PMID:21231916) showed by direct assay that DNAJB8 localizes to the cytosol (IDA for GO:0005829, cytosol). The IBA phylogenetic inference is consistent with experimental data for both DNAJB8 and its close paralogue DNAJB6, which is also cytoplasmic. Note that cytoplasm (GO:0005737) is broader than cytosol (GO:0005829) but the IBA annotation at this level is appropriate given the phylogenetic evidence base.
Reason: Cytoplasmic localization is confirmed by IDA evidence from PMID:21231916 for the more specific term cytosol (GO:0005829), and is consistent with the function of DNAJB8 as a cytoplasmic holdase chaperone that suppresses polyQ aggregation (PMID:20159555). The IBA inference is phylogenetically sound given conservation across DNAJB6/DNAJB8 orthologues.
Supporting Evidence:
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding. Inversely, chaperones that supported luciferase refolding were poor suppressors of polyQ aggregation.
PMID:20159555
members of a subclass of the DNAJB family (particularly DNAJB6b and DNAJB8) are superior suppressors of aggregation and toxicity of disease-associated polyglutamine proteins.
GO:0006457 protein folding
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for protein folding (GO:0006457) is broadly acceptable as DNAJB8 is a J-domain co-chaperone involved in proteostasis. However, DNAJB8 acts primarily as a holdase that suppresses aggregation of polyQ-expanded proteins rather than promoting productive protein folding (PMID:21231916, PMID:20159555). Hageman et al. (PMID:21231916) showed that chaperones suppressing polyQ aggregation (like DNAJB8) could not stimulate luciferase refolding, distinguishing holdase from foldase activities. The term protein folding is therefore somewhat imprecise for DNAJB8, but the broader proteostasis role is real. As an IBA annotation it represents a reasonable phylogenetic inference at an appropriate level of specificity.
Reason: Although DNAJB8 is functionally a holdase rather than a canonical foldase, it participates in the broader protein folding quality control network as a J-domain co-chaperone. The IBA phylogenetic inference is sound for the DNAJB subfamily. The qualifier in GOA is 'involved_in' which is appropriate for a chaperone that participates in protein folding pathways even if its specific role is aggregation suppression rather than productive folding. Experimental support comes from PMID:23612975 (IDA for the same term) and PMID:20159555.
Supporting Evidence:
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding. Inversely, chaperones that supported luciferase refolding were poor suppressors of polyQ aggregation.
PMID:23612975
we expressed polyQ peptides in cells and show that their intracellular aggregation is prevented by DNAJB6 and DNAJB8, members of the DNAJ (Hsp40) chaperone family.
GO:0005634 nucleus
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for nuclear localization is well supported. DNAJB8 has been shown to localize to the nucleus by IDA (PMID:21231916) and HDA (PMID:21630459, sperm nuclear proteomics). The IBA phylogenetic inference is consistent with experimental data for DNAJB8 itself and with the known nuclear localization of its close paralogue DNAJB6a.
Reason: Nuclear localization of DNAJB8 is confirmed by multiple independent lines of evidence: IDA from PMID:21231916 (direct assay showing nuclear localization) and HDA from PMID:21630459 (identified in human sperm nuclear proteome). The IBA phylogenetic inference is consistent with these experimental observations and with the dual cytosol/nucleus localization pattern of the DNAJB6/B8 subfamily.
Supporting Evidence:
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding.
PMID:21630459
403 different proteins have been identified from the isolated sperm nuclei.
GO:0051087 protein-folding chaperone binding
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for protein-folding chaperone binding (GO:0051087) is well supported. DNAJB8 is a J-domain co-chaperone that physically interacts with Hsp70 family members (HSPA1A/P0DMV8, HSPA1B/P0DMV9, HSPA6/P17066) as shown by IPI evidence from PMID:21231916. The J-domain of DNAJB8 stimulates Hsp70 ATPase activity, which is the canonical mechanism of J-domain protein function. The IBA phylogenetic inference is consistent with this being a core function of J-domain proteins across the DNAJB subfamily.
Reason: Chaperone binding is a core molecular function of J-domain proteins. DNAJB8 contains a canonical J-domain (residues 3-69, UniProt) that mediates interaction with Hsp70 chaperones. IPI evidence from PMID:21231916 directly demonstrates physical interaction with multiple Hsp70 family members. The IBA phylogenetic inference is phylogenetically sound and at the right level of specificity.
Supporting Evidence:
PMID:20159555
The antiaggregation activity is largely independent of the N-terminal Hsp70-interacting J-domain. Rather, a C-terminal serine-rich (SSF-SST) region and the C-terminal tail are essential.
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding.
GO:0044183 protein folding chaperone
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for protein folding chaperone (GO:0044183) is well supported and represents a core molecular function of DNAJB8. This term describes the activity of binding to a protein to assist the protein folding process, which is the canonical function of J-domain co-chaperones. DNAJB8 specifically acts as a holdase chaperone that binds polyQ-expanded proteins and other aggregation-prone substrates to prevent their aggregation (PMID:20159555, PMID:23612975). IDA evidence for this same term exists from PMID:23612975. The IBA phylogenetic inference is sound and at the right level of specificity for the DNAJB subfamily.
Reason: GO:0044183 (protein folding chaperone) is the best available GO molecular function term for DNAJB8's holdase/anti-aggregation chaperone activity. DNAJB8 binds aggregation-prone substrates to prevent their misfolding and aggregation, which falls within the scope of this term. IDA evidence from PMID:23612975 independently supports this annotation. The IBA phylogenetic inference is consistent with the conserved chaperone function across the DNAJB6/B8 clade.
Supporting Evidence:
PMID:23612975
we conclude that the mechanism of DNAJB6 and DNAJB8 is suppression of polyQ protein aggregation by directly binding the polyQ tract.
PMID:20159555
members of a subclass of the DNAJB family (particularly DNAJB6b and DNAJB8) are superior suppressors of aggregation and toxicity of disease-associated polyglutamine proteins.
GO:0051082 unfolded protein binding
IBA
GO_REF:0000033
MODIFY
Summary: GO:0051082 (unfolded protein binding) is being obsoleted (go-ontology#30962). While DNAJB8 does bind unfolded/aggregation-prone substrates, this term does not accurately capture its functional activity. DNAJB8 is a holdase chaperone that binds polyQ-expanded proteins and other aggregation-prone substrates to prevent their aggregation, largely independently of Hsp70 (PMID:20159555). The best available replacement term is GO:0044183 (protein folding chaperone), which is already annotated via IBA and IDA evidence for this gene. Note that DNAJB8 is functionally a holdase rather than a foldase, but no dedicated holdase term currently exists in GO.
Reason: GO:0051082 is being obsoleted. DNAJB8 does bind unfolded/misfolded proteins, but this binding is in the context of its holdase chaperone activity -- it prevents aggregation of polyQ substrates rather than merely binding unfolded proteins passively. The recommended interim replacement is GO:0044183 (protein folding chaperone), which better captures the functional activity, though it is imprecise for a holdase. DNAJB8 already has GO:0044183 annotations (IBA and IDA), so this modification aligns the annotation set. Hageman et al. (PMID:20159555) showed that the anti-aggregation activity of DNAJB8 is largely independent of the J-domain and resides in the C-terminal serine-rich region, demonstrating direct substrate binding in a holdase capacity. Gillis et al. (PMID:23612975) confirmed that DNAJB6 and DNAJB8 inhibit polyQ peptide aggregation directly by binding the polyQ tract.
Proposed replacements: protein folding chaperone
Supporting Evidence:
PMID:20159555
members of a subclass of the DNAJB family (particularly DNAJB6b and DNAJB8) are superior suppressors of aggregation and toxicity of disease-associated polyglutamine proteins. The antiaggregation activity is largely independent of the N-terminal Hsp70-interacting J-domain. Rather, a C-terminal serine-rich (SSF-SST) region and the C-terminal tail are essential. The SSF-SST region is involved in substrate binding, formation of polydisperse oligomeric complexes, and interaction with histone deacetylases (HDAC4, HDAC6, SIRT2).
PMID:23612975
we conclude that the mechanism of DNAJB6 and DNAJB8 is suppression of polyQ protein aggregation by directly binding the polyQ tract.
GO:0005737 cytoplasm
IEA
GO_REF:0000117
ACCEPT
Summary: IEA annotation for cytoplasm localization from ARBA machine learning models. This is consistent with the IBA annotation for cytoplasm and the IDA annotation for the more specific term cytosol (GO:0005829) from PMID:21231916. The IEA annotation is broader than the experimentally determined cytosol localization but is not incorrect.
Reason: Cytoplasmic localization is confirmed by IDA evidence for cytosol (PMID:21231916) and by IBA phylogenetic inference. The IEA annotation is redundant with but consistent with higher-quality evidence. Acceptable as a broader computational annotation that aligns with experimental data.
Supporting Evidence:
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding.
GO:0030544 Hsp70 protein binding
IEA
GO_REF:0000002
ACCEPT
Summary: IEA annotation for Hsp70 protein binding (GO:0030544) inferred from the InterPro domain IPR043183 (DNJB2/6-like). DNAJB8 contains a canonical J-domain (residues 3-69) that mediates physical interaction with Hsp70 family chaperones. Hageman et al. (PMID:21231916) demonstrated by IPI that DNAJB8 physically interacts with HSPA1A (P0DMV8), HSPA1B (P0DMV9), and HSPA6 (P17066), all Hsp70 family members. While the IPI annotations are curated under the broader GO:0051087 (protein-folding chaperone binding), Hsp70 binding is a well-established core function of J-domain proteins. This IEA annotation is more specific than GO:0051087 regarding the binding partner identity and is well supported.
Reason: Hsp70 binding is the canonical function of J-domain proteins. DNAJB8 has a well-characterized J-domain (UniProt domain annotation, residues 3-69) and IPI evidence from PMID:21231916 confirms physical interaction with three Hsp70 family members. The InterPro-based IEA inference from IPR043183 is correct and specific. Hageman et al. (PMID:20159555) further showed that while the antiaggregation activity of DNAJB8 is largely J-domain independent, the J-domain still mediates Hsp70 interaction.
Supporting Evidence:
PMID:20159555
The antiaggregation activity is largely independent of the N-terminal Hsp70-interacting J-domain. Rather, a C-terminal serine-rich (SSF-SST) region and the C-terminal tail are essential.
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding.
GO:0051082 unfolded protein binding
IEA
GO_REF:0000002
MODIFY
Summary: GO:0051082 (unfolded protein binding) is being obsoleted (go-ontology#30962). This IEA annotation was inferred from the InterPro domain IPR043183 (DNJB2/6-like), which is shared across DNAJB2, DNAJB6, and DNAJB8. While these proteins do interact with unfolded/misfolded substrates, the term fails to capture the functional nature of the interaction. DNAJB8 specifically acts as a holdase chaperone that suppresses aggregation of polyQ-expanded proteins by directly binding the polyQ tract (PMID:20159555, PMID:23612975). The best interim replacement is GO:0044183 (protein folding chaperone), noting that DNAJB8 is a holdase rather than a foldase and no dedicated holdase GO term currently exists.
Reason: GO:0051082 is being obsoleted. The InterPro-based IEA mapping from IPR043183 correctly identified that DNAJB8 interacts with unfolded substrates, but GO:0044183 (protein folding chaperone) is the recommended replacement that better captures the functional chaperone activity. DNAJB8 already has GO:0044183 annotations from both IBA and IDA evidence. Caveat: DNAJB8 functions as a holdase rather than a foldase -- it suppresses aggregation rather than promoting productive folding -- but GO currently lacks a dedicated holdase term.
Proposed replacements: protein folding chaperone
Supporting Evidence:
PMID:20159555
members of a subclass of the DNAJB family (particularly DNAJB6b and DNAJB8) are superior suppressors of aggregation and toxicity of disease-associated polyglutamine proteins. The antiaggregation activity is largely independent of the N-terminal Hsp70-interacting J-domain.
PMID:23612975
we conclude that the mechanism of DNAJB6 and DNAJB8 is suppression of polyQ protein aggregation by directly binding the polyQ tract.
GO:0051087 protein-folding chaperone binding
IEA
GO_REF:0000117
ACCEPT
Summary: IEA annotation for protein-folding chaperone binding from ARBA machine learning models. This is consistent with the IBA annotation and the IPI evidence from PMID:21231916 showing DNAJB8 physically interacts with Hsp70 chaperones (HSPA1A, HSPA1B, HSPA6). The computational inference is correct and redundant with higher-quality evidence.
Reason: Protein-folding chaperone binding is well established for DNAJB8 through IPI evidence (PMID:21231916) and IBA phylogenetic inference. The IEA annotation is redundant with but consistent with these higher-quality annotations.
Supporting Evidence:
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding.
GO:0090084 negative regulation of inclusion body assembly
IEA
GO_REF:0000117
ACCEPT
Summary: IEA annotation for negative regulation of inclusion body assembly from ARBA machine learning models. DNAJB8 is a potent suppressor of polyQ protein aggregation and inclusion body formation (PMID:20159555, PMID:23612975). Hageman et al. (PMID:20159555) demonstrated that DNAJB8 suppresses aggregation and toxicity of disease-associated polyglutamine proteins. Gillis et al. (PMID:23612975) showed that DNAJB8 prevents intracellular aggregation of polyQ peptides. This is a core function of DNAJB8 and the IEA annotation is well supported by IDA evidence from PMID:21231916 for the same term.
Reason: Negative regulation of inclusion body assembly is a core function of DNAJB8, supported by IDA evidence from PMID:21231916 and extensive experimental literature (PMID:20159555, PMID:23612975). The IEA annotation is redundant with but consistent with the higher-quality IDA annotation.
Supporting Evidence:
PMID:20159555
members of a subclass of the DNAJB family (particularly DNAJB6b and DNAJB8) are superior suppressors of aggregation and toxicity of disease-associated polyglutamine proteins.
PMID:23612975
we expressed polyQ peptides in cells and show that their intracellular aggregation is prevented by DNAJB6 and DNAJB8, members of the DNAJ (Hsp40) chaperone family.
GO:0051087 protein-folding chaperone binding
IPI
PMID:21231916
The diverse members of the mammalian HSP70 machine show dist...
ACCEPT
Summary: IPI annotation for protein-folding chaperone binding based on physical interaction evidence from Hageman et al. (PMID:21231916). The GOA records three separate IPI entries for this annotation, each with a different Hsp70 interacting partner: HSPA1A (UniProtKB:P0DMV8), HSPA1B (UniProtKB:P0DMV9), and HSPA6 (UniProtKB:P17066). This study systematically tested the chaperone activities of HSP70 and DNAJ family members and demonstrated physical interactions between DNAJB8 and these Hsp70 proteins. DNAJB8 contains a canonical J-domain (residues 3-69) that mediates Hsp70 interaction. This is a core molecular function of J-domain co-chaperones.
Reason: Physical interaction between DNAJB8 and Hsp70 chaperones is directly demonstrated by co-immunoprecipitation or equivalent assays in Hageman et al. (PMID:21231916). The J-domain of DNAJB8 is the canonical Hsp70 interaction module. This annotation is well supported and represents a core function. The term protein-folding chaperone binding (GO:0051087) is appropriate as it captures the interaction with Hsp70 chaperones, which are protein-folding chaperones.
Supporting Evidence:
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding. Inversely, chaperones that supported luciferase refolding were poor suppressors of polyQ aggregation.
PMID:20159555
The antiaggregation activity is largely independent of the N-terminal Hsp70-interacting J-domain. Rather, a C-terminal serine-rich (SSF-SST) region and the C-terminal tail are essential.
GO:0005634 nucleus
IDA
PMID:21231916
The diverse members of the mammalian HSP70 machine show dist...
ACCEPT
Summary: IDA annotation for nuclear localization from Hageman et al. (PMID:21231916). This study examined the subcellular localization of overexpressed DNAJB8 using fluorescence microscopy or similar direct assays, demonstrating both nuclear and cytosolic localization. Nuclear localization is independently supported by the HDA annotation from PMID:21630459 (sperm nuclear proteomics) and the IBA phylogenetic inference. The close paralogue DNAJB6 also shows nuclear localization, with the DNAJB6a isoform being predominantly nuclear. DNAJB8 localizes to both cytosol and nucleus, consistent with the description in UniProt.
Reason: Nuclear localization is directly demonstrated by Hageman et al. (PMID:21231916) and independently confirmed by sperm nuclear proteomics (PMID:21630459). The dual cytosol/nucleus localization is consistent with the known biology of the DNAJB6/B8 subfamily and with a potential role in nuclear proteostasis.
Supporting Evidence:
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding.
PMID:21630459
403 different proteins have been identified from the isolated sperm nuclei.
GO:0005829 cytosol
IDA
PMID:21231916
The diverse members of the mammalian HSP70 machine show dist...
ACCEPT
Summary: IDA annotation for cytosol localization from Hageman et al. (PMID:21231916). DNAJB8 was shown by direct assay to localize to the cytosol. This is consistent with its function as a cytoplasmic holdase chaperone that suppresses polyQ protein aggregation (PMID:20159555, PMID:23612975). The cytosol is the primary site where DNAJB8 encounters and binds aggregation-prone substrates. This is also consistent with the IBA annotation for the broader term cytoplasm (GO:0005737).
Reason: Cytosolic localization is directly demonstrated by Hageman et al. (PMID:21231916) and is consistent with the primary function of DNAJB8 as a cytoplasmic holdase chaperone. The cytosol is where polyQ-expanded proteins aggregate and where DNAJB8 exerts its anti-aggregation activity.
Supporting Evidence:
PMID:20159555
members of a subclass of the DNAJB family (particularly DNAJB6b and DNAJB8) are superior suppressors of aggregation and toxicity of disease-associated polyglutamine proteins.
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding.
GO:0051082 unfolded protein binding
IDA
PMID:21231916
The diverse members of the mammalian HSP70 machine show dist...
MODIFY
Summary: GO:0051082 (unfolded protein binding) is being obsoleted (go-ontology#30962). This IDA annotation cites PMID:21231916 (Hageman et al. 2011), which demonstrated that different HSP70/DNAJ family members have distinct chaperone-like activities. Chaperones that suppressed polyQ aggregation (holdase activity) were found not to stimulate luciferase refolding (foldase activity), and vice versa (PMID:21231916). DNAJB8 falls in the holdase category. The earlier study by the same group (PMID:20159555, Hageman et al. 2010) specifically showed DNAJB8 is a superior suppressor of polyQ aggregation with activity largely independent of its J-domain. Gillis et al. (PMID:23612975) further confirmed that DNAJB8 suppresses polyQ protein aggregation by directly binding the polyQ tract. The best interim replacement is GO:0044183 (protein folding chaperone), with the caveat that DNAJB8 is a holdase, not a foldase, and no dedicated holdase GO term currently exists.
Reason: GO:0051082 is being obsoleted. The experimental evidence from Hageman et al. (PMID:21231916) demonstrated that DNAJB8 has chaperone-like holdase activity rather than mere unfolded protein binding. The study showed that chaperones suppressing polyQ aggregation could not stimulate luciferase refolding, establishing a functional distinction between holdase and foldase activities. GO:0044183 (protein folding chaperone) is the best available replacement term, though it is imprecise for a holdase. DNAJB8 already has GO:0044183 annotations from IBA and IDA (PMID:23612975) evidence. The IDA evidence supporting the original GO:0051082 annotation is consistent with chaperone activity and should be retained under the replacement term.
Proposed replacements: protein folding chaperone
Supporting Evidence:
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding. Inversely, chaperones that supported luciferase refolding were poor suppressors of polyQ aggregation. This was not related to client specificity itself, as the polyQ aggregation inhibitors often also suppressed heat-induced aggregation of luciferase.
PMID:20159555
members of a subclass of the DNAJB family (particularly DNAJB6b and DNAJB8) are superior suppressors of aggregation and toxicity of disease-associated polyglutamine proteins. The antiaggregation activity is largely independent of the N-terminal Hsp70-interacting J-domain. Rather, a C-terminal serine-rich (SSF-SST) region and the C-terminal tail are essential.
PMID:23612975
we expressed polyQ peptides in cells and show that their intracellular aggregation is prevented by DNAJB6 and DNAJB8, members of the DNAJ (Hsp40) chaperone family. In contrast, HSPA/Hsp70 and DNAJB1, also members of the DNAJ chaperone family, did not prevent peptide-initiated aggregation.
GO:0090084 negative regulation of inclusion body assembly
IDA
PMID:21231916
The diverse members of the mammalian HSP70 machine show dist...
ACCEPT
Summary: IDA annotation for negative regulation of inclusion body assembly from Hageman et al. (PMID:21231916). This study demonstrated that DNAJB8 suppresses polyQ aggregation, which directly manifests as prevention of inclusion body formation. The earlier study by the same group (PMID:20159555) showed DNAJB8 is a superior suppressor of aggregation and toxicity of disease-associated polyglutamine proteins, with the antiaggregation activity residing in the C-terminal serine-rich region. Gillis et al. (PMID:23612975) independently confirmed that DNAJB8 prevents intracellular aggregation of polyQ peptides by directly binding the polyQ tract. This is a core function of DNAJB8 and the annotation is well supported by direct experimental evidence.
Reason: Negative regulation of inclusion body assembly is directly demonstrated by multiple studies. Hageman et al. (PMID:21231916) showed DNAJB8 suppresses polyQ aggregation in cellular assays. The same group (PMID:20159555) established the mechanism involving C-terminal substrate binding and HDAC interactions. Gillis et al. (PMID:23612975) confirmed DNAJB8 prevents intracellular polyQ peptide aggregation. This is arguably the most distinctive and potent function of DNAJB8.
Supporting Evidence:
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding. Inversely, chaperones that supported luciferase refolding were poor suppressors of polyQ aggregation.
PMID:20159555
members of a subclass of the DNAJB family (particularly DNAJB6b and DNAJB8) are superior suppressors of aggregation and toxicity of disease-associated polyglutamine proteins. The antiaggregation activity is largely independent of the N-terminal Hsp70-interacting J-domain.
PMID:23612975
we expressed polyQ peptides in cells and show that their intracellular aggregation is prevented by DNAJB6 and DNAJB8, members of the DNAJ (Hsp40) chaperone family. In contrast, HSPA/Hsp70 and DNAJB1, also members of the DNAJ chaperone family, did not prevent peptide-initiated aggregation.
GO:0005634 nucleus
HDA
PMID:21630459
Proteomic characterization of the human sperm nucleus.
ACCEPT
Summary: HDA annotation for nuclear localization from de Mateo et al. (PMID:21630459), a proteomic characterization of the human sperm nucleus. DNAJB8 was identified among 403 proteins in isolated human sperm nuclei by LC-MS/MS. DNAJB8 is enriched in testis (HPA: tissue enriched in testis; Bgee: expressed in sperm), so its detection in the sperm nuclear proteome is biologically plausible. However, this is a high-throughput proteomics study and the nuclear detection could reflect a genuine nuclear pool or could be a consequence of the protein being highly abundant in testis. The nuclear localization is independently supported by IDA evidence from PMID:21231916. DNAJB8 is known to localize to both cytosol and nucleus.
Reason: The HDA evidence from sperm nuclear proteomics is consistent with the IDA evidence for nuclear localization from PMID:21231916 and with the IBA phylogenetic inference. While high-throughput proteomics can have contaminants, the fact that DNAJB8 is testis-enriched and independently shown to be nuclear by direct assay supports the biological relevance of this detection. The annotation is well corroborated.
Supporting Evidence:
PMID:21630459
With this approach, 403 different proteins have been identified from the isolated sperm nuclei. The most abundant family of proteins identified are the histones, for which several novel members had not been reported previously as present in the spermatogenic cell line or in the human mature spermatozoa.
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding.
GO:0006457 protein folding
IDA
PMID:23612975
The DNAJB6 and DNAJB8 protein chaperones prevent intracellul...
ACCEPT
Summary: IDA annotation for protein folding (GO:0006457) from Gillis et al. (PMID:23612975). The GOA qualifier is 'acts_upstream_of_or_within', which indicates involvement in the broader process. Gillis et al. demonstrated that DNAJB8 prevents intracellular aggregation of polyQ peptides by directly binding the polyQ tract, placing it in the protein folding quality control pathway. DNAJB8 functions as a holdase rather than a foldase -- Hageman et al. (PMID:21231916) showed that chaperones suppressing polyQ aggregation could not stimulate luciferase refolding. The term protein folding is therefore somewhat imprecise for DNAJB8, but the broader proteostasis role is real and the qualifier 'acts_upstream_of_or_within' appropriately captures the indirect relationship.
Reason: DNAJB8 is a J-domain co-chaperone that participates in protein folding quality control, specifically by preventing aggregation of misfolded proteins. The qualifier 'acts_upstream_of_or_within' is appropriate as DNAJB8 acts within the protein folding process by suppressing aggregation rather than directly catalyzing productive folding. The IDA evidence from Gillis et al. (PMID:23612975) directly demonstrates this anti-aggregation activity in cellular assays with polyQ peptides.
Supporting Evidence:
PMID:23612975
we expressed polyQ peptides in cells and show that their intracellular aggregation is prevented by DNAJB6 and DNAJB8, members of the DNAJ (Hsp40) chaperone family. In contrast, HSPA/Hsp70 and DNAJB1, also members of the DNAJ chaperone family, did not prevent peptide-initiated aggregation.
PMID:21231916
Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding. Inversely, chaperones that supported luciferase refolding were poor suppressors of polyQ aggregation.
GO:0044183 protein folding chaperone
IDA
PMID:23612975
The DNAJB6 and DNAJB8 protein chaperones prevent intracellul...
ACCEPT
Summary: IDA annotation for protein folding chaperone (GO:0044183) from Gillis et al. (PMID:23612975). This study demonstrated that DNAJB8 prevents intracellular aggregation of polyQ peptides by directly binding the polyQ tract, establishing DNAJB8 as a chaperone that binds proteins to assist in the protein folding process (by preventing misfolding/aggregation). Hageman et al. (PMID:20159555) previously established that DNAJB8 is a superior suppressor of polyQ protein aggregation with activity residing in the C-terminal serine-rich region. This is a core molecular function of DNAJB8 and GO:0044183 is the best available GO term for its holdase chaperone activity.
Reason: GO:0044183 (protein folding chaperone) is the most appropriate molecular function term for DNAJB8. The IDA evidence from Gillis et al. (PMID:23612975) directly demonstrates that DNAJB8 binds polyQ substrates to prevent their aggregation, which falls within the scope of this term. This is also the recommended replacement term for the obsoleting GO:0051082 (unfolded protein binding). The annotation is independently supported by IBA phylogenetic inference for the same term.
Supporting Evidence:
PMID:23612975
we conclude that the mechanism of DNAJB6 and DNAJB8 is suppression of polyQ protein aggregation by directly binding the polyQ tract.
PMID:20159555
members of a subclass of the DNAJB family (particularly DNAJB6b and DNAJB8) are superior suppressors of aggregation and toxicity of disease-associated polyglutamine proteins. The antiaggregation activity is largely independent of the N-terminal Hsp70-interacting J-domain.

Core Functions

Holdase chaperone that potently suppresses aggregation of polyglutamine- expanded proteins and other aggregation-prone substrates. DNAJB8 uses at least two distinct substrate-binding modes: (1) a serine-rich stretch in the S/T-rich region for fibrillar/amyloid aggregation suppression by directly binding the polyQ tract, and (2) a separate C-terminal TTK-LKS motif for amorphous inclusion suppression via Hsp70-dependent proteasomal degradation (DOI:10.1242/jcs.255596). The anti-aggregation activity is largely independent of the N-terminal J-domain/HSP70-stimulating activity and requires interaction with histone deacetylases (HDAC4, HDAC6, SIRT2) (PMID:20159555). A key regulatory mechanism is an intramolecular JD-CTD interaction that sequesters the J-domain surface and controls Hsp70 recruitment as a reversible switch (DOI:10.1038/s41467-021-21147-x). DNAJB8 self-assembles into oligomeric puncta via an AFSSFN (147-152) steric-zipper motif (resolved at 0.75 angstrom by MicroED), but oligomerization is dispensable for substrate binding and anti-aggregation function (DOI:10.1016/j.str.2024.02.015). DNAJB8 cannot stimulate luciferase refolding, distinguishing its holdase mechanism from foldase-type chaperones (PMID:21231916).

Supporting Evidence:
  • PMID:20159555
    members of a subclass of the DNAJB family (particularly DNAJB6b and DNAJB8) are superior suppressors of aggregation and toxicity of disease-associated polyglutamine proteins. The antiaggregation activity is largely independent of the N-terminal Hsp70-interacting J-domain. Rather, a C-terminal serine-rich (SSF-SST) region and the C-terminal tail are essential.
  • PMID:23612975
    we conclude that the mechanism of DNAJB6 and DNAJB8 is suppression of polyQ protein aggregation by directly binding the polyQ tract.
  • PMID:21231916
    Overexpressed chaperones that suppressed polyQ aggregation were found not to be able to stimulate luciferase refolding. Inversely, chaperones that supported luciferase refolding were poor suppressors of polyQ aggregation.

References

Gene Ontology annotation through association of InterPro records with GO terms
Annotation inferences using phylogenetic trees
Electronic Gene Ontology annotations created by ARBA machine learning models
A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation.
The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities.
Proteomic characterization of the human sperm nucleus.
The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides.
DOI:10.1016/j.str.2024.02.015
DNAJB8 oligomerization is mediated by an aromatic-rich motif that is dispensable for substrate activity.
  • AFSSFN (147-152) steric-zipper motif resolved at 0.75 angstrom by MicroED as a class 6 steric zipper stabilized by aromatic interactions (F148, F151); F151 is a primary driver of full-length DNAJB8 self-assembly.
  • Engineered monomeric DNAJB8 variants retain substrate binding and anti-aggregation function, demonstrating oligomerization is mechanistically separable from chaperone activity.
DOI:10.1038/s41467-021-21147-x
Regulatory inter-domain interactions influence Hsp70 recruitment to the DnaJB8 chaperone.
  • Intramolecular JD-CTD interaction sequesters the J-domain surface, preventing Hsp70 interaction as a reversible regulatory switch controlling Hsp70 recruitment.
  • DNAJB8-Clover forms juxtanuclear puncta in 39.2 +/- 3.1% of cells vs 0.44 +/- 0.50% for Clover control.
DOI:10.1242/jcs.255596
DNAJB chaperones suppress destabilised protein aggregation via a region distinct from that used to inhibit amyloidogenesis.
  • Distinct substrate-binding modes in DNAJB8: serine-rich stretch needed for fibrillar/amyloid aggregation suppression but not for FlucDM inclusion suppression; a separate CTD TTK-LKS motif is required for amorphous inclusion suppression via Hsp70-dependent proteasomal degradation.
DOI:10.1158/0008-5472.CAN-11-3062
HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells.
  • DNAJB8 preferentially expressed in renal cancer stem-like/cancer-initiating cell populations; overexpression increases side population fraction and tumor-initiating ability.
DOI:10.1038/s41419-022-04599-x
DNAJB8 in small extracellular vesicles promotes oxaliplatin resistance through TP53/MDR1 pathway in colon cancer.
  • DNAJB8 interacts with TP53 and inhibits TP53 ubiquitination, stabilizing TP53 and leading to MDR1/P-gp upregulation and increased oxaliplatin resistance; sEV-mediated transfer propagates resistance.
DOI:10.1038/s41416-020-1017-1
Development of an artificial antibody specific for HLA/peptide complex derived from cancer stem-like cell/cancer-initiating cell antigen DNAJB8.
  • Engineered antibodies targeting HLA-A24/DNAJB8-derived peptide complex achieve nanomolar affinity (KD 2.96-5.04 nM) and mediate CDC and bispecific antibody-dependent cellular cytotoxicity.

📚 Additional Documentation

Deep Research Falcon

(DNAJB8-deep-research-falcon.md)

provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-20T14:57:14.717292'
end_time: '2026-02-20T15:11:06.844857'
duration_seconds: 832.13
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: DNAJB8
gene_symbol: DNAJB8
uniprot_accession: Q8NHS0
protein_description: 'RecName: Full=DnaJ homolog subfamily B member 8;'
gene_info: Name=DNAJB8;
organism_full: Homo sapiens (Human).
protein_family: Not specified in UniProt
protein_domains: DnaJ_domain. (IPR001623); DnaJ_domain_CS. (IPR018253); DNJB2/6-like.
(IPR043183); J_dom_sf. (IPR036869); DnaJ (PF00226)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 19


Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

  • UniProt Accession: Q8NHS0
  • Protein Description: RecName: Full=DnaJ homolog subfamily B member 8;
  • Gene Information: Name=DNAJB8;
  • Organism (full): Homo sapiens (Human).
  • Protein Family: Not specified in UniProt
  • Key Domains: DnaJ_domain. (IPR001623); DnaJ_domain_CS. (IPR018253); DNJB2/6-like. (IPR043183); J_dom_sf. (IPR036869); DnaJ (PF00226)

MANDATORY VERIFICATION STEPS:

  1. Check if the gene symbol "DNAJB8" matches the protein description above
  2. Verify the organism is correct: Homo sapiens (Human).
  3. Check if protein family/domains align with what you find in literature
  4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'DNAJB8' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene DNAJB8 (gene ID: DNAJB8, UniProt: Q8NHS0) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

  • UniProt Accession: Q8NHS0
  • Protein Description: RecName: Full=DnaJ homolog subfamily B member 8;
  • Gene Information: Name=DNAJB8;
  • Organism (full): Homo sapiens (Human).
  • Protein Family: Not specified in UniProt
  • Key Domains: DnaJ_domain. (IPR001623); DnaJ_domain_CS. (IPR018253); DNJB2/6-like. (IPR043183); J_dom_sf. (IPR036869); DnaJ (PF00226)

MANDATORY VERIFICATION STEPS:

  1. Check if the gene symbol "DNAJB8" matches the protein description above
  2. Verify the organism is correct: Homo sapiens (Human).
  3. Check if protein family/domains align with what you find in literature
  4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'DNAJB8' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene DNAJB8 (gene ID: DNAJB8, UniProt: Q8NHS0) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Title: Functional annotation research report for human DNAJB8 (UniProt Q8NHS0)

Publication date of report: 2026-02-20

  1. Target verification (gene/protein identity)
    DNAJB8 (UniProt Q8NHS0) encodes “DnaJ homolog subfamily B member 8”, a member of the HSP40/J-domain protein (JDP) family in Homo sapiens, studied experimentally as a chaperone/co-chaperone in proteostasis and as a cancer-testis antigen in cancer stem-like cell (CSC/CIC)-directed immunotherapy. Its experimentally described domain architecture (N-terminal J-domain, G/F-rich region, S/T-rich region, C-terminal domain) matches the UniProt/InterPro expectation for a class B DNAJ protein. (ryder2021regulatoryinterdomaininteractions pages 1-2)

  2. Key concepts and current mechanistic understanding
    2.1 Definitions and conceptual framework
    DNAJB8 is a J-domain protein (Hsp40 family) that functions within the Hsp70 chaperone system by regulating client recognition/handling and (in many JDPs) stimulating Hsp70 ATPase activity via the J-domain; however, DNAJB8 also exhibits strong “holdase” anti-aggregation activity that can be partly independent of canonical J-domain/Hsp70 co-chaperone action depending on the client and assay context. (hageman2010adnajbchaperone pages 1-2, mcmahon2021dnajbchaperonessuppress pages 1-2)

2.2 Domain architecture and regulatory model
Structural/biophysical evidence supports that DNAJB8 contains: (i) an N-terminal J-domain (JD), (ii) a G/F-rich region, (iii) an S/T-rich region, and (iv) a C-terminal domain (CTD). A key regulatory mechanism is an intramolecular JD–CTD interaction that can sequester the JD surface, thereby preventing Hsp70 interaction; this has been proposed as a reversible “switch” that controls Hsp70 recruitment. (ryder2021regulatoryinterdomaininteractions pages 1-2)

2.3 Cellular localization and self-assembly
In cells, DNAJB8 can self-assemble/oligomerize and form juxtanuclear puncta. In a quantitative imaging readout, overexpressed DnaJB8–Clover formed juxtanuclear puncta (~1.0 µm) in 39.2 ± 3.1% of cells compared with 0.44 ± 0.50% for Clover control; reduced expression decreased puncta frequency to 16.2 ± 0.08%. (ryder2021regulatoryinterdomaininteractions pages 1-2)

2.4 Anti-aggregation/proteostasis functions and client-handling modes
Multiple studies place DNAJB8 among the most potent anti-aggregation DNAJBs, particularly against polyglutamine (polyQ) aggregation.

• PolyQ and related toxic aggregation suppression: DNAJB8 (with DNAJB6b) was identified as a superior suppressor of aggregation and toxicity of disease-associated polyQ proteins. This activity can be largely independent of the Hsp70-interacting J-domain and instead requires a C-terminal serine-rich region and tail, linking substrate binding/holdase activity to low-complexity C-terminal features. (hageman2010adnajbchaperone pages 1-2)

• Distinct substrate-binding regions for amyloid vs non-amyloid inclusions: Using a destabilized firefly luciferase reporter (FlucDM), DNAJB8 suppresses inclusion formation by promoting Hsp70-dependent proteasomal degradation of the client. For DNAJB6/DNAJB8, a serine-rich stretch needed to prevent fibrillar/amyloid aggregation was not required for FlucDM inclusion suppression; instead, a distinct C-terminal TTK-LKS motif was required to inhibit FlucDM inclusion formation, supporting at least two separable client-interaction modes. (mcmahon2021dnajbchaperonessuppress pages 1-2)

• HDAC-linked regulation: DNAJB8’s polyQ anti-aggregation function was reported to involve a serine-rich region and C-terminal tail, and to be associated with HDAC-dependent activities; DNAJB8 was reported to interact with HDAC4/HDAC6/SIRT2, and its activity was sensitive to pharmacological HDAC4 inhibition. (hageman2010adnajbchaperone pages 1-2)

  1. Recent developments and latest research (priority 2023–2024)
    3.1 2024: Oligomerization mechanism resolved at atomic resolution and decoupled from chaperone function
    A 2024 Structure paper identified a short aromatic-rich steric-zipper motif within the S/T-rich domain (147AFSSFN152) as a principal determinant of DNAJB8 self-assembly. MicroED at 0.75 Å revealed a class 6 steric zipper stabilized by aromatic interactions (notably F148 and F151) and antiparallel β-strand hydrogen bonding. Mutational analysis indicated F151 is a primary driver of full-length DNAJB8 self-assembly. Importantly, engineered monomeric/non-assembling DNAJB8 variants retained substrate binding and anti-aggregation function, supporting a model in which oligomerization is mechanistically separable from chaperone activity for several tested substrates. (ryder2024dnajb8oligomerizationis pages 29-36, ryder2024dnajb8oligomerizationis pages 3-5, ryder2024dnajb8oligomerizationis pages 1-3)

Quantitative/experimental data highlights from this 2024 work include:
• DLS-derived hydrodynamic radius (Rh) differences across mutants (e.g., DNAJB8WT initial Rh = 7.9 ± 0.2 nm; DNAJB8S3 Rh = 2.4 ± 0.1 nm). (ryder2024dnajb8oligomerizationis pages 3-5)
• SEC-MALS evidence that a monomeric variant (DNAJB8S3) was predominantly monomeric (99.3% mass) with molar mass 25.45 ± 0.016 kg/mol; similarly the F148S/F151S double mutant yielded 93% as a single peak with molar mass 25.8 ± 0.2 kg/mol. (ryder2024dnajb8oligomerizationis pages 29-36, ryder2024dnajb8oligomerizationis pages 3-5)
• In a tau seeding cellular readout, seeded cells expressing mRuby3 alone were 16.5 ± 2.5% tau-positive; DNAJB8WT reduced tau FRET seeding signal by ~2-fold and oligomerization-defective mutants were not significantly different from DNAJB8WT in tau suppression in the tested comparisons. (ryder2024dnajb8oligomerizationis pages 11-13)

3.2 2023–2024 translational trend: DNAJB8 as a CSC/CIC antigen and cancer-testis antigen target
Although many foundational DNAJB8 cancer-immunology studies are earlier (2012–2020), a notable 2022–2024 theme is positioning DNAJB8 as a candidate target in CSC/CIC-directed immunotherapy and precision targeting via HLA/peptide recognition.

  1. Biological roles in disease and cancer (mechanistic evidence)
    4.1 Cancer stem-like cells / tumor-initiating capacity
    A highly cited Cancer Research study (2012) identified DNAJB8 as preferentially expressed in renal cancer CSC/CIC populations and implicated it functionally in maintaining tumor-initiating ability. Overexpression increased the side population (SP) fraction and tumor-initiating ability, whereas attenuation decreased SP cells and reduced tumor initiation. (nishizawa2012hspdnajb8controls pages 1-2)

A follow-up in colorectal cancer CSC/CIC context showed DNAJB8 preferential expression in CRC CSC/CIC, enhancement of stem-cell marker expression and tumorigenicity when overexpressed, and induction of DNAJB8-specific CTL responses. (nishizawa2012hspdnajb8controls pages 1-2)

4.2 Chemotherapy resistance in colon cancer via TP53/MDR1 and extracellular vesicle transfer
A 2022 Cell Death & Disease study provided mechanistic evidence linking DNAJB8 to oxaliplatin resistance in colon cancer. Key claims supported by experimental evidence include:
• DNAJB8 interacts with TP53 and inhibits TP53 ubiquitination, stabilizing TP53 protein and leading to MDR1/P-gp upregulation and increased oxaliplatin resistance. (wang2022dnajb8insmall pages 5-6, wang2022dnajb8insmall pages 1-2)
• DNAJB8 is enriched in conditioned medium and in small extracellular vesicles (sEVs) from oxaliplatin-resistant cells, and sEV-mediated transfer of DNAJB8 can transmit resistance to recipient (sensitive) cells; inhibition of EV transfer (e.g., using GW4869) blocked transfer-mediated resistance features. (wang2022dnajb8insmall pages 7-9, wang2022dnajb8insmall pages 9-10)
• Protein-level changes consistent with this pathway are visualized in Western blots showing multi-fold increases in DNAJB8, TP53, and P-gp in resistant/sEV transfer contexts; an example densitometry indicates TP53 increased up to ~5.4-fold, P-gp up to ~4.1-fold, and DNAJB8 up to ~3.8-fold in the reported conditions. (wang2022dnajb8insmall pages 10-11, wang2022dnajb8insmall media 4a707267)

Clinical/prognostic modeling reported in this study supports a potential biomarker role:
• DNAJB8 levels were associated with TP53 expression in COAD (P < 0.001). (wang2022dnajb8insmall pages 7-9)
• A prognostic nomogram incorporating DNAJB8 and clinicopathologic factors achieved a C-index of 0.841 (95% CI 0.802–0.880), and ROC AUCs reported for survival prediction included 0.848 (2-year), 0.713 (3-year), and 0.776 (4-year). (wang2022dnajb8insmall pages 7-9, wang2022dnajb8insmall media 058578fa)
• Kaplan–Meier analysis of a signature stratifying patients into high vs low risk showed significantly worse overall survival in the high-risk group (p < 0.0001). (wang2022dnajb8insmall media 058578fa)

  1. Current applications and real-world implementations
    5.1 Antigen-specific targeting approaches (HLA/peptide-directed biologics)
    A 2020 British Journal of Cancer study developed engineered antibodies recognizing an HLA-A24/DNAJB8-derived peptide complex (DNAJB8_143), demonstrating feasibility of targeting DNAJB8-derived antigen presentation rather than the intracellular chaperone directly. Phage-display isolated scFv clones (A10, B10) were engineered into human IgG1 and CD3-engaging bispecific formats.

Quantitative binding and functional metrics include:
• High-affinity binding to cognate HLA/peptide complex: KD = 2.96 × 10−9 M (A10-hIgG1) and KD = 5.04 × 10−9 M (B10-hIgG1). (tadano2020developmentofan pages 1-2)
• Antibody formats mediated complement-dependent cytotoxicity (CDC) and CD3-engaging bispecific antibody-dependent cellular cytotoxicity (BADCC), with B10-(CD3×JB8) reported as superior to A10-(CD3×JB8) in BADCC. (tadano2020developmentofan pages 1-2)

These data support an application path where DNAJB8 serves as a CSC/CIC-associated antigenic source for HLA-restricted targeting modalities. (tadano2020developmentofan pages 1-2, nishizawa2012hspdnajb8controls pages 1-2)

5.2 Biomarker potential in liquid biopsy (serum sEVs)
The 2022 colon cancer study specifically argues that DNAJB8 levels in serum sEVs may serve as a biomarker for oxaliplatin-resistant colon cancer and for prognostic stratification, supported by survival separation, a high C-index nomogram, and AUC values for survival prediction. (wang2022dnajb8insmall pages 7-9, wang2022dnajb8insmall media 058578fa)

  1. Expert opinions and integrative analysis from authoritative sources
    A 2022 review of DNAJB proteins in cancer emphasizes that DNAJB8 is experimentally implicated in CSC/CIC maintenance in RCC and CRC, can be induced by HSF1 (co-regulated with SOX2), and has been proposed as an immunotherapy target; it also summarizes evidence linking DNAJB8 to TP53 regulation and MDR1-mediated chemoresistance, including transfer via small extracellular vesicles and correlation with poor overall survival in colon cancer contexts. (kim2022multifacetedrolesof pages 7-9)

  2. Relevant statistics and quantitative data (selected)
    Chaperone biology / structure:
    • JD–CTD regulated Hsp70 recruitment model; puncta formation frequency: 39.2 ± 3.1% of cells (DNAJB8–Clover) vs 0.44 ± 0.50% (Clover), with reduced-expression puncta frequency 16.2 ± 0.08%. (ryder2021regulatoryinterdomaininteractions pages 1-2)
    • 2024 steric-zipper assembly motif: 147AFSSFN152; SEC-MALS monomeric variants ~25.45 ± 0.016 kg/mol (99.3% monomeric mass) and 25.8 ± 0.2 kg/mol (93% single peak) for F148S/F151S double mutant; DLS Rh differences including DNAJB8WT initial Rh 7.9 ± 0.2 nm and DNAJB8S3 Rh 2.4 ± 0.1 nm. (ryder2024dnajb8oligomerizationis pages 29-36, ryder2024dnajb8oligomerizationis pages 3-5)

Cancer immunotherapy / targeting:
• scFv/IgG affinities for HLA-A24/DNAJB8 peptide complex: KD = 2.96 × 10−9 M and 5.04 × 10−9 M. (tadano2020developmentofan pages 1-2)

Colon cancer chemoresistance / prognosis:
• Nomogram prognostic performance: C-index 0.841 (95% CI 0.802–0.880); AUCs 0.848 (2-year), 0.713 (3-year), 0.776 (4-year); Kaplan–Meier risk group separation p < 0.0001. (wang2022dnajb8insmall pages 7-9, wang2022dnajb8insmall media 058578fa)
• Western blot densitometry in EV transfer/resistance context indicates multi-fold increases (e.g., TP53 up to ~5.4-fold, P-gp up to ~4.1-fold, DNAJB8 up to ~3.8-fold). (wang2022dnajb8insmall pages 10-11, wang2022dnajb8insmall media 4a707267)

  1. Pathways and cellular context summary (functional annotation)
    • Core molecular function: DNAJB8 is a molecular chaperone/co-chaperone (J-domain protein) that suppresses aggregation of misfolded proteins and can route destabilized clients toward Hsp70-dependent proteasomal degradation; it also forms oligomeric assemblies/puncta and is regulated by inter-domain interactions that modulate Hsp70 recruitment. (mcmahon2021dnajbchaperonessuppress pages 1-2, ryder2021regulatoryinterdomaininteractions pages 1-2, hageman2010adnajbchaperone pages 1-2)
    • Proteostasis network placement: DNAJB8 is part of the Hsp40/Hsp70 system and interfaces with protein quality control; distinct motifs in its low-complexity regions mediate client-type-specific suppression (amyloid vs amorphous inclusion). (mcmahon2021dnajbchaperonessuppress pages 1-2, hageman2010adnajbchaperone pages 1-2)
    • Cancer-relevant pathway: DNAJB8 can promote chemoresistance in colon cancer by stabilizing TP53 (inhibiting ubiquitination-mediated degradation) leading to MDR1/P-gp upregulation; sEV transfer propagates this resistance phenotype. (wang2022dnajb8insmall pages 5-6, wang2022dnajb8insmall pages 7-9)
    • CSC/CIC biology: DNAJB8 supports CSC/CIC phenotypes and tumor-initiating capacity in RCC and CRC models and can be exploited as an antigenic target for CTL responses or HLA/peptide-directed antibody strategies. (nishizawa2012hspdnajb8controls pages 1-2, tadano2020developmentofan pages 1-2)

  2. Limitations and evidence gaps
    • Several clinically relevant claims (e.g., hazard ratios, precise IC50 shifts, exact responder/nonresponder serum levels) were referenced qualitatively in available excerpts but not always available as explicit numeric values in the extracted text segments; where possible, quantitative model metrics (C-index/AUC) and figure-based fold-changes were captured. (wang2022dnajb8insmall pages 7-9, wang2022dnajb8insmall pages 10-11)
    • The tool-retrieved corpus contained strong mechanistic and translational evidence up to 2024, but did not yield DNAJB8-specific 2023–2024 randomized clinical trial evidence; clinical trial searches returned no clearly relevant registered trials in the retrieved state. (tadano2020developmentofan pages 1-2, wang2022dnajb8insmall pages 7-9)

Key cited primary sources (URLs and publication dates)
• Ryder BD et al. “DNAJB8 oligomerization is mediated by an aromatic-rich motif that is dispensable for substrate activity.” Structure. 2024-06. https://doi.org/10.1016/j.str.2024.02.015 (ryder2024dnajb8oligomerizationis pages 29-36)
• Ryder BD et al. “Regulatory inter-domain interactions influence Hsp70 recruitment to the DnaJB8 chaperone.” Nature Communications. 2021-02. https://doi.org/10.1038/s41467-021-21147-x (ryder2021regulatoryinterdomaininteractions pages 1-2)
• Wang Z-m et al. “DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53/MDR1 pathway in colon cancer.” Cell Death & Disease. 2022-02. https://doi.org/10.1038/s41419-022-04599-x (wang2022dnajb8insmall pages 7-9)
• Tadano H et al. “Development of an artificial antibody specific for HLA/peptide complex derived from cancer stem-like cell/cancer-initiating cell antigen DNAJB8.” British Journal of Cancer. 2020-08. https://doi.org/10.1038/s41416-020-1017-1 (tadano2020developmentofan pages 1-2)
• Nishizawa S et al. “HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells.” Cancer Research. 2012-06. https://doi.org/10.1158/0008-5472.CAN-11-3062 (nishizawa2012hspdnajb8controls pages 1-2)
• Hageman J et al. “A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic protein aggregation.” Molecular Cell. 2010-02. https://doi.org/10.1016/j.molcel.2010.01.001 (hageman2010adnajbchaperone pages 1-2)

References

  1. (ryder2021regulatoryinterdomaininteractions pages 1-2): Bryan D. Ryder, Irina Matlahov, Sofia Bali, Jaime Vaquer-Alicea, Patrick C. A. van der Wel, and Lukasz A. Joachimiak. Regulatory inter-domain interactions influence hsp70 recruitment to the dnajb8 chaperone. Nature Communications, Feb 2021. URL: https://doi.org/10.1038/s41467-021-21147-x, doi:10.1038/s41467-021-21147-x. This article has 35 citations and is from a highest quality peer-reviewed journal.

  2. (hageman2010adnajbchaperone pages 1-2): Jurre Hageman, Maria A. Rujano, Maria A.W.H. van Waarde, Vaishali Kakkar, Ron P. Dirks, Natalia Govorukhina, Henderika M.J. Oosterveld-Hut, Nicolette H. Lubsen, and Harm H. Kampinga. A dnajb chaperone subfamily with hdac-dependent activities suppresses toxic protein aggregation. Molecular cell, 37 3:355-69, Feb 2010. URL: https://doi.org/10.1016/j.molcel.2010.01.001, doi:10.1016/j.molcel.2010.01.001. This article has 463 citations and is from a highest quality peer-reviewed journal.

  3. (mcmahon2021dnajbchaperonessuppress pages 1-2): Shannon McMahon, Steven Bergink, Harm H. Kampinga, and Heath Ecroyd. Dnajb chaperones suppress destabilised protein aggregation via a region distinct from that used to inhibit amyloidogenesis. Journal of Cell Science, Apr 2021. URL: https://doi.org/10.1242/jcs.255596, doi:10.1242/jcs.255596. This article has 29 citations and is from a domain leading peer-reviewed journal.

  4. (ryder2024dnajb8oligomerizationis pages 29-36): Bryan D. Ryder, Elizaveta Ustyantseva, David R. Boyer, Ayde Mendoza-Oliva, Mikołaj I. Kuska, Paweł M. Wydorski, Paulina Macierzyńska, Nabil Morgan, Michael R. Sawaya, Marc I. Diamond, Harm H. Kampinga, and Lukasz A. Joachimiak. Dnajb8 oligomerization is mediated by an aromatic-rich motif that is dispensable for substrate activity. Jun 2024. URL: https://doi.org/10.1016/j.str.2024.02.015, doi:10.1016/j.str.2024.02.015. This article has 22 citations and is from a domain leading peer-reviewed journal.

  5. (ryder2024dnajb8oligomerizationis pages 3-5): Bryan D. Ryder, Elizaveta Ustyantseva, David R. Boyer, Ayde Mendoza-Oliva, Mikołaj I. Kuska, Paweł M. Wydorski, Paulina Macierzyńska, Nabil Morgan, Michael R. Sawaya, Marc I. Diamond, Harm H. Kampinga, and Lukasz A. Joachimiak. Dnajb8 oligomerization is mediated by an aromatic-rich motif that is dispensable for substrate activity. Jun 2024. URL: https://doi.org/10.1016/j.str.2024.02.015, doi:10.1016/j.str.2024.02.015. This article has 22 citations and is from a domain leading peer-reviewed journal.

  6. (ryder2024dnajb8oligomerizationis pages 1-3): Bryan D. Ryder, Elizaveta Ustyantseva, David R. Boyer, Ayde Mendoza-Oliva, Mikołaj I. Kuska, Paweł M. Wydorski, Paulina Macierzyńska, Nabil Morgan, Michael R. Sawaya, Marc I. Diamond, Harm H. Kampinga, and Lukasz A. Joachimiak. Dnajb8 oligomerization is mediated by an aromatic-rich motif that is dispensable for substrate activity. Jun 2024. URL: https://doi.org/10.1016/j.str.2024.02.015, doi:10.1016/j.str.2024.02.015. This article has 22 citations and is from a domain leading peer-reviewed journal.

  7. (ryder2024dnajb8oligomerizationis pages 11-13): Bryan D. Ryder, Elizaveta Ustyantseva, David R. Boyer, Ayde Mendoza-Oliva, Mikołaj I. Kuska, Paweł M. Wydorski, Paulina Macierzyńska, Nabil Morgan, Michael R. Sawaya, Marc I. Diamond, Harm H. Kampinga, and Lukasz A. Joachimiak. Dnajb8 oligomerization is mediated by an aromatic-rich motif that is dispensable for substrate activity. Jun 2024. URL: https://doi.org/10.1016/j.str.2024.02.015, doi:10.1016/j.str.2024.02.015. This article has 22 citations and is from a domain leading peer-reviewed journal.

  8. (nishizawa2012hspdnajb8controls pages 1-2): Satoshi Nishizawa, Yoshihiko Hirohashi, Toshihiko Torigoe, Akari Takahashi, Yasuaki Tamura, Takashi Mori, Takayuki Kanaseki, Kenjiro Kamiguchi, Hiroko Asanuma, Rena Morita, Alice Sokolovskaya, Junichi Matsuzaki, Ren Yamada, Reona Fujii, Harm H. Kampinga, Toru Kondo, Tadashi Hasegawa, Isao Hara, and Noriyuki Sato. Hsp dnajb8 controls tumor-initiating ability in renal cancer stem-like cells. Cancer research, 72 11:2844-54, Jun 2012. URL: https://doi.org/10.1158/0008-5472.can-11-3062, doi:10.1158/0008-5472.can-11-3062. This article has 144 citations and is from a highest quality peer-reviewed journal.

  9. (wang2022dnajb8insmall pages 5-6): Zheng-min Wang, Yi Li, Rui Mao, Yu Zhang, J. Wen, Qian Liu, Yanjun Liu, and Tongtong Zhang. Dnajb8 in small extracellular vesicles promotes oxaliplatin resistance through tp53/mdr1 pathway in colon cancer. Cell Death & Disease, Feb 2022. URL: https://doi.org/10.1038/s41419-022-04599-x, doi:10.1038/s41419-022-04599-x. This article has 19 citations and is from a peer-reviewed journal.

  10. (wang2022dnajb8insmall pages 1-2): Zheng-min Wang, Yi Li, Rui Mao, Yu Zhang, J. Wen, Qian Liu, Yanjun Liu, and Tongtong Zhang. Dnajb8 in small extracellular vesicles promotes oxaliplatin resistance through tp53/mdr1 pathway in colon cancer. Cell Death & Disease, Feb 2022. URL: https://doi.org/10.1038/s41419-022-04599-x, doi:10.1038/s41419-022-04599-x. This article has 19 citations and is from a peer-reviewed journal.

  11. (wang2022dnajb8insmall pages 7-9): Zheng-min Wang, Yi Li, Rui Mao, Yu Zhang, J. Wen, Qian Liu, Yanjun Liu, and Tongtong Zhang. Dnajb8 in small extracellular vesicles promotes oxaliplatin resistance through tp53/mdr1 pathway in colon cancer. Cell Death & Disease, Feb 2022. URL: https://doi.org/10.1038/s41419-022-04599-x, doi:10.1038/s41419-022-04599-x. This article has 19 citations and is from a peer-reviewed journal.

  12. (wang2022dnajb8insmall pages 9-10): Zheng-min Wang, Yi Li, Rui Mao, Yu Zhang, J. Wen, Qian Liu, Yanjun Liu, and Tongtong Zhang. Dnajb8 in small extracellular vesicles promotes oxaliplatin resistance through tp53/mdr1 pathway in colon cancer. Cell Death & Disease, Feb 2022. URL: https://doi.org/10.1038/s41419-022-04599-x, doi:10.1038/s41419-022-04599-x. This article has 19 citations and is from a peer-reviewed journal.

  13. (wang2022dnajb8insmall pages 10-11): Zheng-min Wang, Yi Li, Rui Mao, Yu Zhang, J. Wen, Qian Liu, Yanjun Liu, and Tongtong Zhang. Dnajb8 in small extracellular vesicles promotes oxaliplatin resistance through tp53/mdr1 pathway in colon cancer. Cell Death & Disease, Feb 2022. URL: https://doi.org/10.1038/s41419-022-04599-x, doi:10.1038/s41419-022-04599-x. This article has 19 citations and is from a peer-reviewed journal.

  14. (wang2022dnajb8insmall media 4a707267): Zheng-min Wang, Yi Li, Rui Mao, Yu Zhang, J. Wen, Qian Liu, Yanjun Liu, and Tongtong Zhang. Dnajb8 in small extracellular vesicles promotes oxaliplatin resistance through tp53/mdr1 pathway in colon cancer. Cell Death & Disease, Feb 2022. URL: https://doi.org/10.1038/s41419-022-04599-x, doi:10.1038/s41419-022-04599-x. This article has 19 citations and is from a peer-reviewed journal.

  15. (wang2022dnajb8insmall media 058578fa): Zheng-min Wang, Yi Li, Rui Mao, Yu Zhang, J. Wen, Qian Liu, Yanjun Liu, and Tongtong Zhang. Dnajb8 in small extracellular vesicles promotes oxaliplatin resistance through tp53/mdr1 pathway in colon cancer. Cell Death & Disease, Feb 2022. URL: https://doi.org/10.1038/s41419-022-04599-x, doi:10.1038/s41419-022-04599-x. This article has 19 citations and is from a peer-reviewed journal.

  16. (tadano2020developmentofan pages 1-2): Hiroki Tadano, Tomohide Tsukahara, Emi Mizushima, Asuka Akamatsu, Kazue Watanabe, Iyori Nojima, Terufumi Kubo, Takayuki Kanaseki, Yoshihiko Hirohashi, Noriyuki Sato, and Toshihiko Torigoe. Development of an artificial antibody specific for hla/peptide complex derived from cancer stem-like cell/cancer-initiating cell antigen dnajb8. British Journal of Cancer, 123:1387-1394, Aug 2020. URL: https://doi.org/10.1038/s41416-020-1017-1, doi:10.1038/s41416-020-1017-1. This article has 10 citations and is from a domain leading peer-reviewed journal.

  17. (kim2022multifacetedrolesof pages 7-9): Hye-Youn Kim and Suntaek Hong. Multi-faceted roles of dnajb protein in cancer metastasis and clinical implications. International Journal of Molecular Sciences, 23:14970, Nov 2022. URL: https://doi.org/10.3390/ijms232314970, doi:10.3390/ijms232314970. This article has 25 citations.

Citations

  1. ryder2021regulatoryinterdomaininteractions pages 1-2
  2. hageman2010adnajbchaperone pages 1-2
  3. mcmahon2021dnajbchaperonessuppress pages 1-2
  4. tadano2020developmentofan pages 1-2
  5. kim2022multifacetedrolesof pages 7-9
  6. https://doi.org/10.1016/j.str.2024.02.015
  7. https://doi.org/10.1038/s41467-021-21147-x
  8. https://doi.org/10.1038/s41419-022-04599-x
  9. https://doi.org/10.1038/s41416-020-1017-1
  10. https://doi.org/10.1158/0008-5472.CAN-11-3062
  11. https://doi.org/10.1016/j.molcel.2010.01.001
  12. https://doi.org/10.1038/s41467-021-21147-x,
  13. https://doi.org/10.1016/j.molcel.2010.01.001,
  14. https://doi.org/10.1242/jcs.255596,
  15. https://doi.org/10.1016/j.str.2024.02.015,
  16. https://doi.org/10.1158/0008-5472.can-11-3062,
  17. https://doi.org/10.1038/s41419-022-04599-x,
  18. https://doi.org/10.1038/s41416-020-1017-1,
  19. https://doi.org/10.3390/ijms232314970,

📄 View Raw YAML

id: Q8NHS0
gene_symbol: DNAJB8
product_type: PROTEIN
status: IN_PROGRESS
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  DNAJB8 is a class B J-domain protein (Hsp40/DNAJ family, subfamily B) that
  functions as a potent holdase chaperone suppressing polyglutamine and other
  aggregation-prone protein aggregation. Its domain architecture comprises an
  N-terminal J-domain (JD), a G/F-rich region, an S/T-rich region containing
  the key 147-AFSSFN-152 steric-zipper oligomerization motif, and a C-terminal
  domain (CTD). A key regulatory mechanism is an intramolecular JD-CTD
  interaction that can sequester the JD surface and control Hsp70 recruitment
  as a reversible switch (DOI:10.1038/s41467-021-21147-x). Unlike canonical
  DNAJ co-chaperones that assist Hsp70-mediated protein refolding, DNAJB8 acts
  primarily as a holdase, with anti-aggregation activity largely independent of
  the J-domain residing in the C-terminal serine-rich (SSF-SST) region and
  C-terminal tail (PMID:20159555). DNAJB8 self-assembles into oligomeric puncta
  via the AFSSFN steric-zipper motif (resolved at 0.75 angstrom by MicroED,
  class 6 steric zipper), but engineered monomeric variants retain substrate
  binding and anti-aggregation function, demonstrating that oligomerization is
  mechanistically separable from chaperone activity (DOI:10.1016/j.str.2024.02.015).
  DNAJB8 uses distinct substrate-binding modes: a serine-rich stretch for
  fibrillar/amyloid aggregation suppression and a separate CTD TTK-LKS motif
  for amorphous inclusion suppression via Hsp70-dependent proteasomal degradation
  (DOI:10.1242/jcs.255596). DNAJB8 is also a cancer-testis antigen preferentially
  expressed in renal and colorectal cancer stem-like cells, controlling
  tumor-initiating capacity (DOI:10.1158/0008-5472.CAN-11-3062), and promotes
  oxaliplatin chemoresistance in colon cancer via TP53 stabilization leading to
  MDR1/P-gp upregulation (DOI:10.1038/s41419-022-04599-x). DNAJB8 is enriched
  in testis but expressed in multiple tissues, and localizes to both cytosol and
  nucleus.
existing_annotations:
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IBA annotation for cytoplasm localization is well supported. DNAJB8 is a
      cytoplasmic J-domain co-chaperone. Hageman et al. (PMID:21231916) showed by
      direct assay that DNAJB8 localizes to the cytosol (IDA for GO:0005829,
      cytosol). The IBA phylogenetic inference is consistent with experimental
      data for both DNAJB8 and its close paralogue DNAJB6, which is also
      cytoplasmic. Note that cytoplasm (GO:0005737) is broader than cytosol
      (GO:0005829) but the IBA annotation at this level is appropriate given the
      phylogenetic evidence base.
    action: ACCEPT
    reason: >-
      Cytoplasmic localization is confirmed by IDA evidence from PMID:21231916
      for the more specific term cytosol (GO:0005829), and is consistent with the
      function of DNAJB8 as a cytoplasmic holdase chaperone that suppresses polyQ
      aggregation (PMID:20159555). The IBA inference is phylogenetically sound
      given conservation across DNAJB6/DNAJB8 orthologues.
    supported_by:
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding. Inversely, chaperones that
        supported luciferase refolding were poor suppressors of polyQ aggregation.
    - reference_id: PMID:20159555
      supporting_text: >-
        members of a subclass of the DNAJB family (particularly DNAJB6b and
        DNAJB8) are superior suppressors of aggregation and toxicity of
        disease-associated polyglutamine proteins.
- term:
    id: GO:0006457
    label: protein folding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IBA annotation for protein folding (GO:0006457) is broadly acceptable as
      DNAJB8 is a J-domain co-chaperone involved in proteostasis. However,
      DNAJB8 acts primarily as a holdase that suppresses aggregation of
      polyQ-expanded proteins rather than promoting productive protein folding
      (PMID:21231916, PMID:20159555). Hageman et al. (PMID:21231916) showed that
      chaperones suppressing polyQ aggregation (like DNAJB8) could not stimulate
      luciferase refolding, distinguishing holdase from foldase activities.
      The term protein folding is therefore somewhat imprecise for DNAJB8, but
      the broader proteostasis role is real. As an IBA annotation it represents a
      reasonable phylogenetic inference at an appropriate level of specificity.
    action: ACCEPT
    reason: >-
      Although DNAJB8 is functionally a holdase rather than a canonical foldase,
      it participates in the broader protein folding quality control network as a
      J-domain co-chaperone. The IBA phylogenetic inference is sound for the DNAJB
      subfamily. The qualifier in GOA is 'involved_in' which is appropriate for a
      chaperone that participates in protein folding pathways even if its specific
      role is aggregation suppression rather than productive folding. Experimental
      support comes from PMID:23612975 (IDA for the same term) and PMID:20159555.
    supported_by:
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding. Inversely, chaperones that
        supported luciferase refolding were poor suppressors of polyQ aggregation.
    - reference_id: PMID:23612975
      supporting_text: >-
        we expressed polyQ peptides in cells and show that their intracellular
        aggregation is prevented by DNAJB6 and DNAJB8, members of the DNAJ
        (Hsp40) chaperone family.
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IBA annotation for nuclear localization is well supported. DNAJB8 has been
      shown to localize to the nucleus by IDA (PMID:21231916) and HDA
      (PMID:21630459, sperm nuclear proteomics). The IBA phylogenetic inference
      is consistent with experimental data for DNAJB8 itself and with the known
      nuclear localization of its close paralogue DNAJB6a.
    action: ACCEPT
    reason: >-
      Nuclear localization of DNAJB8 is confirmed by multiple independent lines
      of evidence: IDA from PMID:21231916 (direct assay showing nuclear
      localization) and HDA from PMID:21630459 (identified in human sperm nuclear
      proteome). The IBA phylogenetic inference is consistent with these
      experimental observations and with the dual cytosol/nucleus localization
      pattern of the DNAJB6/B8 subfamily.
    supported_by:
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding.
    - reference_id: PMID:21630459
      supporting_text: >-
        403 different proteins have been identified from the isolated sperm
        nuclei.
- term:
    id: GO:0051087
    label: protein-folding chaperone binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IBA annotation for protein-folding chaperone binding (GO:0051087) is well
      supported. DNAJB8 is a J-domain co-chaperone that physically interacts with
      Hsp70 family members (HSPA1A/P0DMV8, HSPA1B/P0DMV9, HSPA6/P17066) as
      shown by IPI evidence from PMID:21231916. The J-domain of DNAJB8 stimulates
      Hsp70 ATPase activity, which is the canonical mechanism of J-domain protein
      function. The IBA phylogenetic inference is consistent with this being a
      core function of J-domain proteins across the DNAJB subfamily.
    action: ACCEPT
    reason: >-
      Chaperone binding is a core molecular function of J-domain proteins.
      DNAJB8 contains a canonical J-domain (residues 3-69, UniProt) that mediates
      interaction with Hsp70 chaperones. IPI evidence from PMID:21231916 directly
      demonstrates physical interaction with multiple Hsp70 family members. The
      IBA phylogenetic inference is phylogenetically sound and at the right level
      of specificity.
    supported_by:
    - reference_id: PMID:20159555
      supporting_text: >-
        The antiaggregation activity is largely independent of the N-terminal
        Hsp70-interacting J-domain. Rather, a C-terminal serine-rich (SSF-SST)
        region and the C-terminal tail are essential.
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding.
- term:
    id: GO:0044183
    label: protein folding chaperone
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      IBA annotation for protein folding chaperone (GO:0044183) is well supported
      and represents a core molecular function of DNAJB8. This term describes the
      activity of binding to a protein to assist the protein folding process,
      which is the canonical function of J-domain co-chaperones. DNAJB8
      specifically acts as a holdase chaperone that binds polyQ-expanded proteins
      and other aggregation-prone substrates to prevent their aggregation
      (PMID:20159555, PMID:23612975). IDA evidence for this same term exists from
      PMID:23612975. The IBA phylogenetic inference is sound and at the right
      level of specificity for the DNAJB subfamily.
    action: ACCEPT
    reason: >-
      GO:0044183 (protein folding chaperone) is the best available GO molecular
      function term for DNAJB8's holdase/anti-aggregation chaperone activity.
      DNAJB8 binds aggregation-prone substrates to prevent their misfolding and
      aggregation, which falls within the scope of this term. IDA evidence from
      PMID:23612975 independently supports this annotation. The IBA phylogenetic
      inference is consistent with the conserved chaperone function across the
      DNAJB6/B8 clade.
    supported_by:
    - reference_id: PMID:23612975
      supporting_text: >-
        we conclude that the mechanism of DNAJB6 and DNAJB8 is suppression of
        polyQ protein aggregation by directly binding the polyQ tract.
    - reference_id: PMID:20159555
      supporting_text: >-
        members of a subclass of the DNAJB family (particularly DNAJB6b and
        DNAJB8) are superior suppressors of aggregation and toxicity of
        disease-associated polyglutamine proteins.
- term:
    id: GO:0051082
    label: unfolded protein binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: >-
      GO:0051082 (unfolded protein binding) is being obsoleted (go-ontology#30962).
      While DNAJB8 does bind unfolded/aggregation-prone substrates, this term
      does not accurately capture its functional activity. DNAJB8 is a holdase
      chaperone that binds polyQ-expanded proteins and other aggregation-prone
      substrates to prevent their aggregation, largely independently of Hsp70
      (PMID:20159555). The best available replacement term is GO:0044183 (protein
      folding chaperone), which is already annotated via IBA and IDA evidence for
      this gene. Note that DNAJB8 is functionally a holdase rather than a foldase,
      but no dedicated holdase term currently exists in GO.
    action: MODIFY
    reason: >-
      GO:0051082 is being obsoleted. DNAJB8 does bind unfolded/misfolded proteins,
      but this binding is in the context of its holdase chaperone activity --
      it prevents aggregation of polyQ substrates rather than merely binding
      unfolded proteins passively. The recommended interim replacement is
      GO:0044183 (protein folding chaperone), which better captures the functional
      activity, though it is imprecise for a holdase. DNAJB8 already has
      GO:0044183 annotations (IBA and IDA), so this modification aligns the
      annotation set. Hageman et al. (PMID:20159555) showed that the
      anti-aggregation activity of DNAJB8 is largely independent of the J-domain
      and resides in the C-terminal serine-rich region, demonstrating direct
      substrate binding in a holdase capacity. Gillis et al. (PMID:23612975)
      confirmed that DNAJB6 and DNAJB8 inhibit polyQ peptide aggregation
      directly by binding the polyQ tract.
    proposed_replacement_terms:
    - id: GO:0044183
      label: protein folding chaperone
    additional_reference_ids:
    - PMID:20159555
    - PMID:23612975
    supported_by:
    - reference_id: PMID:20159555
      supporting_text: >-
        members of a subclass of the DNAJB family (particularly DNAJB6b and
        DNAJB8) are superior suppressors of aggregation and toxicity of
        disease-associated polyglutamine proteins. The antiaggregation activity
        is largely independent of the N-terminal Hsp70-interacting J-domain.
        Rather, a C-terminal serine-rich (SSF-SST) region and the C-terminal
        tail are essential. The SSF-SST region is involved in substrate binding,
        formation of polydisperse oligomeric complexes, and interaction with
        histone deacetylases (HDAC4, HDAC6, SIRT2).
    - reference_id: PMID:23612975
      supporting_text: >-
        we conclude that the mechanism of DNAJB6 and DNAJB8 is suppression of
        polyQ protein aggregation by directly binding the polyQ tract.
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      IEA annotation for cytoplasm localization from ARBA machine learning
      models. This is consistent with the IBA annotation for cytoplasm and the
      IDA annotation for the more specific term cytosol (GO:0005829) from
      PMID:21231916. The IEA annotation is broader than the experimentally
      determined cytosol localization but is not incorrect.
    action: ACCEPT
    reason: >-
      Cytoplasmic localization is confirmed by IDA evidence for cytosol
      (PMID:21231916) and by IBA phylogenetic inference. The IEA annotation is
      redundant with but consistent with higher-quality evidence. Acceptable as a
      broader computational annotation that aligns with experimental data.
    supported_by:
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding.
- term:
    id: GO:0030544
    label: Hsp70 protein binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      IEA annotation for Hsp70 protein binding (GO:0030544) inferred from the
      InterPro domain IPR043183 (DNJB2/6-like). DNAJB8 contains a canonical
      J-domain (residues 3-69) that mediates physical interaction with Hsp70
      family chaperones. Hageman et al. (PMID:21231916) demonstrated by IPI that
      DNAJB8 physically interacts with HSPA1A (P0DMV8), HSPA1B (P0DMV9), and
      HSPA6 (P17066), all Hsp70 family members. While the IPI annotations are
      curated under the broader GO:0051087 (protein-folding chaperone binding),
      Hsp70 binding is a well-established core function of J-domain proteins.
      This IEA annotation is more specific than GO:0051087 regarding the binding
      partner identity and is well supported.
    action: ACCEPT
    reason: >-
      Hsp70 binding is the canonical function of J-domain proteins. DNAJB8 has a
      well-characterized J-domain (UniProt domain annotation, residues 3-69) and
      IPI evidence from PMID:21231916 confirms physical interaction with three
      Hsp70 family members. The InterPro-based IEA inference from IPR043183 is
      correct and specific. Hageman et al. (PMID:20159555) further showed that
      while the antiaggregation activity of DNAJB8 is largely J-domain
      independent, the J-domain still mediates Hsp70 interaction.
    supported_by:
    - reference_id: PMID:20159555
      supporting_text: >-
        The antiaggregation activity is largely independent of the N-terminal
        Hsp70-interacting J-domain. Rather, a C-terminal serine-rich (SSF-SST)
        region and the C-terminal tail are essential.
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding.
- term:
    id: GO:0051082
    label: unfolded protein binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: >-
      GO:0051082 (unfolded protein binding) is being obsoleted (go-ontology#30962).
      This IEA annotation was inferred from the InterPro domain IPR043183
      (DNJB2/6-like), which is shared across DNAJB2, DNAJB6, and DNAJB8. While
      these proteins do interact with unfolded/misfolded substrates, the term
      fails to capture the functional nature of the interaction. DNAJB8
      specifically acts as a holdase chaperone that suppresses aggregation of
      polyQ-expanded proteins by directly binding the polyQ tract (PMID:20159555,
      PMID:23612975). The best interim replacement is GO:0044183 (protein folding
      chaperone), noting that DNAJB8 is a holdase rather than a foldase and no
      dedicated holdase GO term currently exists.
    action: MODIFY
    reason: >-
      GO:0051082 is being obsoleted. The InterPro-based IEA mapping from
      IPR043183 correctly identified that DNAJB8 interacts with unfolded
      substrates, but GO:0044183 (protein folding chaperone) is the recommended
      replacement that better captures the functional chaperone activity. DNAJB8
      already has GO:0044183 annotations from both IBA and IDA evidence. Caveat:
      DNAJB8 functions as a holdase rather than a foldase -- it suppresses
      aggregation rather than promoting productive folding -- but GO currently
      lacks a dedicated holdase term.
    proposed_replacement_terms:
    - id: GO:0044183
      label: protein folding chaperone
    additional_reference_ids:
    - PMID:20159555
    - PMID:23612975
    supported_by:
    - reference_id: PMID:20159555
      supporting_text: >-
        members of a subclass of the DNAJB family (particularly DNAJB6b and
        DNAJB8) are superior suppressors of aggregation and toxicity of
        disease-associated polyglutamine proteins. The antiaggregation activity
        is largely independent of the N-terminal Hsp70-interacting J-domain.
    - reference_id: PMID:23612975
      supporting_text: >-
        we conclude that the mechanism of DNAJB6 and DNAJB8 is suppression of
        polyQ protein aggregation by directly binding the polyQ tract.
- term:
    id: GO:0051087
    label: protein-folding chaperone binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      IEA annotation for protein-folding chaperone binding from ARBA machine
      learning models. This is consistent with the IBA annotation and the IPI
      evidence from PMID:21231916 showing DNAJB8 physically interacts with
      Hsp70 chaperones (HSPA1A, HSPA1B, HSPA6). The computational inference is
      correct and redundant with higher-quality evidence.
    action: ACCEPT
    reason: >-
      Protein-folding chaperone binding is well established for DNAJB8 through
      IPI evidence (PMID:21231916) and IBA phylogenetic inference. The IEA
      annotation is redundant with but consistent with these higher-quality
      annotations.
    supported_by:
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding.
- term:
    id: GO:0090084
    label: negative regulation of inclusion body assembly
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: >-
      IEA annotation for negative regulation of inclusion body assembly from ARBA
      machine learning models. DNAJB8 is a potent suppressor of polyQ protein
      aggregation and inclusion body formation (PMID:20159555, PMID:23612975).
      Hageman et al. (PMID:20159555) demonstrated that DNAJB8 suppresses
      aggregation and toxicity of disease-associated polyglutamine proteins.
      Gillis et al. (PMID:23612975) showed that DNAJB8 prevents intracellular
      aggregation of polyQ peptides. This is a core function of DNAJB8 and the
      IEA annotation is well supported by IDA evidence from PMID:21231916 for
      the same term.
    action: ACCEPT
    reason: >-
      Negative regulation of inclusion body assembly is a core function of
      DNAJB8, supported by IDA evidence from PMID:21231916 and extensive
      experimental literature (PMID:20159555, PMID:23612975). The IEA annotation
      is redundant with but consistent with the higher-quality IDA annotation.
    supported_by:
    - reference_id: PMID:20159555
      supporting_text: >-
        members of a subclass of the DNAJB family (particularly DNAJB6b and
        DNAJB8) are superior suppressors of aggregation and toxicity of
        disease-associated polyglutamine proteins.
    - reference_id: PMID:23612975
      supporting_text: >-
        we expressed polyQ peptides in cells and show that their intracellular
        aggregation is prevented by DNAJB6 and DNAJB8, members of the DNAJ
        (Hsp40) chaperone family.
- term:
    id: GO:0051087
    label: protein-folding chaperone binding
  evidence_type: IPI
  original_reference_id: PMID:21231916
  review:
    summary: >-
      IPI annotation for protein-folding chaperone binding based on physical
      interaction evidence from Hageman et al. (PMID:21231916). The GOA records
      three separate IPI entries for this annotation, each with a different Hsp70
      interacting partner: HSPA1A (UniProtKB:P0DMV8), HSPA1B (UniProtKB:P0DMV9),
      and HSPA6 (UniProtKB:P17066). This study systematically tested the
      chaperone activities of HSP70 and DNAJ family members and demonstrated
      physical interactions between DNAJB8 and these Hsp70 proteins. DNAJB8
      contains a canonical J-domain (residues 3-69) that mediates Hsp70
      interaction. This is a core molecular function of J-domain co-chaperones.
    action: ACCEPT
    reason: >-
      Physical interaction between DNAJB8 and Hsp70 chaperones is directly
      demonstrated by co-immunoprecipitation or equivalent assays in Hageman et
      al. (PMID:21231916). The J-domain of DNAJB8 is the canonical Hsp70
      interaction module. This annotation is well supported and represents a core
      function. The term protein-folding chaperone binding (GO:0051087) is
      appropriate as it captures the interaction with Hsp70 chaperones, which are
      protein-folding chaperones.
    supported_by:
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding. Inversely, chaperones that
        supported luciferase refolding were poor suppressors of polyQ aggregation.
    - reference_id: PMID:20159555
      supporting_text: >-
        The antiaggregation activity is largely independent of the N-terminal
        Hsp70-interacting J-domain. Rather, a C-terminal serine-rich (SSF-SST)
        region and the C-terminal tail are essential.
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:21231916
  review:
    summary: >-
      IDA annotation for nuclear localization from Hageman et al.
      (PMID:21231916). This study examined the subcellular localization of
      overexpressed DNAJB8 using fluorescence microscopy or similar direct
      assays, demonstrating both nuclear and cytosolic localization. Nuclear
      localization is independently supported by the HDA annotation from
      PMID:21630459 (sperm nuclear proteomics) and the IBA phylogenetic
      inference. The close paralogue DNAJB6 also shows nuclear localization,
      with the DNAJB6a isoform being predominantly nuclear. DNAJB8 localizes
      to both cytosol and nucleus, consistent with the description in UniProt.
    action: ACCEPT
    reason: >-
      Nuclear localization is directly demonstrated by Hageman et al.
      (PMID:21231916) and independently confirmed by sperm nuclear proteomics
      (PMID:21630459). The dual cytosol/nucleus localization is consistent with
      the known biology of the DNAJB6/B8 subfamily and with a potential role
      in nuclear proteostasis.
    supported_by:
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding.
    - reference_id: PMID:21630459
      supporting_text: >-
        403 different proteins have been identified from the isolated sperm
        nuclei.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IDA
  original_reference_id: PMID:21231916
  review:
    summary: >-
      IDA annotation for cytosol localization from Hageman et al.
      (PMID:21231916). DNAJB8 was shown by direct assay to localize to the
      cytosol. This is consistent with its function as a cytoplasmic holdase
      chaperone that suppresses polyQ protein aggregation (PMID:20159555,
      PMID:23612975). The cytosol is the primary site where DNAJB8 encounters
      and binds aggregation-prone substrates. This is also consistent with the
      IBA annotation for the broader term cytoplasm (GO:0005737).
    action: ACCEPT
    reason: >-
      Cytosolic localization is directly demonstrated by Hageman et al.
      (PMID:21231916) and is consistent with the primary function of DNAJB8 as
      a cytoplasmic holdase chaperone. The cytosol is where polyQ-expanded
      proteins aggregate and where DNAJB8 exerts its anti-aggregation activity.
    supported_by:
    - reference_id: PMID:20159555
      supporting_text: >-
        members of a subclass of the DNAJB family (particularly DNAJB6b and
        DNAJB8) are superior suppressors of aggregation and toxicity of
        disease-associated polyglutamine proteins.
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding.
- term:
    id: GO:0051082
    label: unfolded protein binding
  evidence_type: IDA
  original_reference_id: PMID:21231916
  review:
    summary: >-
      GO:0051082 (unfolded protein binding) is being obsoleted (go-ontology#30962).
      This IDA annotation cites PMID:21231916 (Hageman et al. 2011), which
      demonstrated that different HSP70/DNAJ family members have distinct
      chaperone-like activities. Chaperones that suppressed polyQ aggregation
      (holdase activity) were found not to stimulate luciferase refolding
      (foldase activity), and vice versa (PMID:21231916). DNAJB8 falls in
      the holdase category. The earlier study by the same group (PMID:20159555,
      Hageman et al. 2010) specifically showed DNAJB8 is a superior suppressor
      of polyQ aggregation with activity largely independent of its J-domain.
      Gillis et al. (PMID:23612975) further confirmed that DNAJB8 suppresses
      polyQ protein aggregation by directly binding the polyQ tract. The best
      interim replacement is GO:0044183 (protein folding chaperone), with the
      caveat that DNAJB8 is a holdase, not a foldase, and no dedicated holdase
      GO term currently exists.
    action: MODIFY
    reason: >-
      GO:0051082 is being obsoleted. The experimental evidence from Hageman et al.
      (PMID:21231916) demonstrated that DNAJB8 has chaperone-like holdase activity
      rather than mere unfolded protein binding. The study showed that chaperones
      suppressing polyQ aggregation could not stimulate luciferase refolding,
      establishing a functional distinction between holdase and foldase activities.
      GO:0044183 (protein folding chaperone) is the best available replacement
      term, though it is imprecise for a holdase. DNAJB8 already has GO:0044183
      annotations from IBA and IDA (PMID:23612975) evidence. The IDA evidence
      supporting the original GO:0051082 annotation is consistent with chaperone
      activity and should be retained under the replacement term.
    proposed_replacement_terms:
    - id: GO:0044183
      label: protein folding chaperone
    additional_reference_ids:
    - PMID:20159555
    - PMID:23612975
    supported_by:
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding. Inversely, chaperones that
        supported luciferase refolding were poor suppressors of polyQ aggregation.
        This was not related to client specificity itself, as the polyQ
        aggregation inhibitors often also suppressed heat-induced aggregation of
        luciferase.
    - reference_id: PMID:20159555
      supporting_text: >-
        members of a subclass of the DNAJB family (particularly DNAJB6b and
        DNAJB8) are superior suppressors of aggregation and toxicity of
        disease-associated polyglutamine proteins. The antiaggregation activity
        is largely independent of the N-terminal Hsp70-interacting J-domain.
        Rather, a C-terminal serine-rich (SSF-SST) region and the C-terminal
        tail are essential.
    - reference_id: PMID:23612975
      supporting_text: >-
        we expressed polyQ peptides in cells and show that their intracellular
        aggregation is prevented by DNAJB6 and DNAJB8, members of the DNAJ
        (Hsp40) chaperone family. In contrast, HSPA/Hsp70 and DNAJB1, also
        members of the DNAJ chaperone family, did not prevent peptide-initiated
        aggregation.
- term:
    id: GO:0090084
    label: negative regulation of inclusion body assembly
  evidence_type: IDA
  original_reference_id: PMID:21231916
  review:
    summary: >-
      IDA annotation for negative regulation of inclusion body assembly from
      Hageman et al. (PMID:21231916). This study demonstrated that DNAJB8
      suppresses polyQ aggregation, which directly manifests as prevention of
      inclusion body formation. The earlier study by the same group
      (PMID:20159555) showed DNAJB8 is a superior suppressor of aggregation
      and toxicity of disease-associated polyglutamine proteins, with the
      antiaggregation activity residing in the C-terminal serine-rich region.
      Gillis et al. (PMID:23612975) independently confirmed that DNAJB8
      prevents intracellular aggregation of polyQ peptides by directly binding
      the polyQ tract. This is a core function of DNAJB8 and the annotation is
      well supported by direct experimental evidence.
    action: ACCEPT
    reason: >-
      Negative regulation of inclusion body assembly is directly demonstrated
      by multiple studies. Hageman et al. (PMID:21231916) showed DNAJB8
      suppresses polyQ aggregation in cellular assays. The same group
      (PMID:20159555) established the mechanism involving C-terminal
      substrate binding and HDAC interactions. Gillis et al. (PMID:23612975)
      confirmed DNAJB8 prevents intracellular polyQ peptide aggregation. This
      is arguably the most distinctive and potent function of DNAJB8.
    additional_reference_ids:
    - PMID:20159555
    - PMID:23612975
    supported_by:
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding. Inversely, chaperones that
        supported luciferase refolding were poor suppressors of polyQ aggregation.
    - reference_id: PMID:20159555
      supporting_text: >-
        members of a subclass of the DNAJB family (particularly DNAJB6b and
        DNAJB8) are superior suppressors of aggregation and toxicity of
        disease-associated polyglutamine proteins. The antiaggregation activity
        is largely independent of the N-terminal Hsp70-interacting J-domain.
    - reference_id: PMID:23612975
      supporting_text: >-
        we expressed polyQ peptides in cells and show that their intracellular
        aggregation is prevented by DNAJB6 and DNAJB8, members of the DNAJ
        (Hsp40) chaperone family. In contrast, HSPA/Hsp70 and DNAJB1, also
        members of the DNAJ chaperone family, did not prevent peptide-initiated
        aggregation.
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: HDA
  original_reference_id: PMID:21630459
  review:
    summary: >-
      HDA annotation for nuclear localization from de Mateo et al.
      (PMID:21630459), a proteomic characterization of the human sperm nucleus.
      DNAJB8 was identified among 403 proteins in isolated human sperm nuclei by
      LC-MS/MS. DNAJB8 is enriched in testis (HPA: tissue enriched in testis;
      Bgee: expressed in sperm), so its detection in the sperm nuclear proteome
      is biologically plausible. However, this is a high-throughput proteomics
      study and the nuclear detection could reflect a genuine nuclear pool or
      could be a consequence of the protein being highly abundant in testis.
      The nuclear localization is independently supported by IDA evidence from
      PMID:21231916. DNAJB8 is known to localize to both cytosol and nucleus.
    action: ACCEPT
    reason: >-
      The HDA evidence from sperm nuclear proteomics is consistent with the IDA
      evidence for nuclear localization from PMID:21231916 and with the IBA
      phylogenetic inference. While high-throughput proteomics can have
      contaminants, the fact that DNAJB8 is testis-enriched and independently
      shown to be nuclear by direct assay supports the biological relevance of
      this detection. The annotation is well corroborated.
    supported_by:
    - reference_id: PMID:21630459
      supporting_text: >-
        With this approach, 403 different proteins have been identified from the
        isolated sperm nuclei. The most abundant family of proteins identified
        are the histones, for which several novel members had not been reported
        previously as present in the spermatogenic cell line or in the human
        mature spermatozoa.
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding.
- term:
    id: GO:0006457
    label: protein folding
  evidence_type: IDA
  original_reference_id: PMID:23612975
  review:
    summary: >-
      IDA annotation for protein folding (GO:0006457) from Gillis et al.
      (PMID:23612975). The GOA qualifier is 'acts_upstream_of_or_within', which
      indicates involvement in the broader process. Gillis et al. demonstrated
      that DNAJB8 prevents intracellular aggregation of polyQ peptides by
      directly binding the polyQ tract, placing it in the protein folding quality
      control pathway. DNAJB8 functions as a holdase rather than a foldase --
      Hageman et al. (PMID:21231916) showed that chaperones suppressing polyQ
      aggregation could not stimulate luciferase refolding. The term protein
      folding is therefore somewhat imprecise for DNAJB8, but the broader
      proteostasis role is real and the qualifier 'acts_upstream_of_or_within'
      appropriately captures the indirect relationship.
    action: ACCEPT
    reason: >-
      DNAJB8 is a J-domain co-chaperone that participates in protein folding
      quality control, specifically by preventing aggregation of misfolded
      proteins. The qualifier 'acts_upstream_of_or_within' is appropriate as
      DNAJB8 acts within the protein folding process by suppressing aggregation
      rather than directly catalyzing productive folding. The IDA evidence from
      Gillis et al. (PMID:23612975) directly demonstrates this anti-aggregation
      activity in cellular assays with polyQ peptides.
    supported_by:
    - reference_id: PMID:23612975
      supporting_text: >-
        we expressed polyQ peptides in cells and show that their intracellular
        aggregation is prevented by DNAJB6 and DNAJB8, members of the DNAJ
        (Hsp40) chaperone family. In contrast, HSPA/Hsp70 and DNAJB1, also
        members of the DNAJ chaperone family, did not prevent peptide-initiated
        aggregation.
    - reference_id: PMID:21231916
      supporting_text: >-
        Overexpressed chaperones that suppressed polyQ aggregation were found not
        to be able to stimulate luciferase refolding. Inversely, chaperones that
        supported luciferase refolding were poor suppressors of polyQ aggregation.
- term:
    id: GO:0044183
    label: protein folding chaperone
  evidence_type: IDA
  original_reference_id: PMID:23612975
  review:
    summary: >-
      IDA annotation for protein folding chaperone (GO:0044183) from Gillis et
      al. (PMID:23612975). This study demonstrated that DNAJB8 prevents
      intracellular aggregation of polyQ peptides by directly binding the polyQ
      tract, establishing DNAJB8 as a chaperone that binds proteins to assist
      in the protein folding process (by preventing misfolding/aggregation).
      Hageman et al. (PMID:20159555) previously established that DNAJB8 is a
      superior suppressor of polyQ protein aggregation with activity residing
      in the C-terminal serine-rich region. This is a core molecular function
      of DNAJB8 and GO:0044183 is the best available GO term for its holdase
      chaperone activity.
    action: ACCEPT
    reason: >-
      GO:0044183 (protein folding chaperone) is the most appropriate molecular
      function term for DNAJB8. The IDA evidence from Gillis et al.
      (PMID:23612975) directly demonstrates that DNAJB8 binds polyQ substrates
      to prevent their aggregation, which falls within the scope of this term.
      This is also the recommended replacement term for the obsoleting
      GO:0051082 (unfolded protein binding). The annotation is independently
      supported by IBA phylogenetic inference for the same term.
    additional_reference_ids:
    - PMID:20159555
    supported_by:
    - reference_id: PMID:23612975
      supporting_text: >-
        we conclude that the mechanism of DNAJB6 and DNAJB8 is suppression of
        polyQ protein aggregation by directly binding the polyQ tract.
    - reference_id: PMID:20159555
      supporting_text: >-
        members of a subclass of the DNAJB family (particularly DNAJB6b and
        DNAJB8) are superior suppressors of aggregation and toxicity of
        disease-associated polyglutamine proteins. The antiaggregation activity
        is largely independent of the N-terminal Hsp70-interacting J-domain.
core_functions:
- description: >-
    Holdase chaperone that potently suppresses aggregation of polyglutamine-
    expanded proteins and other aggregation-prone substrates. DNAJB8 uses at
    least two distinct substrate-binding modes: (1) a serine-rich stretch in the
    S/T-rich region for fibrillar/amyloid aggregation suppression by directly
    binding the polyQ tract, and (2) a separate C-terminal TTK-LKS motif for
    amorphous inclusion suppression via Hsp70-dependent proteasomal degradation
    (DOI:10.1242/jcs.255596). The anti-aggregation activity is largely
    independent of the N-terminal J-domain/HSP70-stimulating activity and
    requires interaction with histone deacetylases (HDAC4, HDAC6, SIRT2)
    (PMID:20159555). A key regulatory mechanism is an intramolecular JD-CTD
    interaction that sequesters the J-domain surface and controls Hsp70
    recruitment as a reversible switch (DOI:10.1038/s41467-021-21147-x).
    DNAJB8 self-assembles into oligomeric puncta via an AFSSFN (147-152)
    steric-zipper motif (resolved at 0.75 angstrom by MicroED), but
    oligomerization is dispensable for substrate binding and anti-aggregation
    function (DOI:10.1016/j.str.2024.02.015). DNAJB8 cannot stimulate
    luciferase refolding, distinguishing its holdase mechanism from foldase-type
    chaperones (PMID:21231916).
  molecular_function:
    id: GO:0044183
    label: protein folding chaperone
  directly_involved_in:
  - id: GO:0090084
    label: negative regulation of inclusion body assembly
  - id: GO:0006457
    label: protein folding
  locations:
  - id: GO:0005829
    label: cytosol
  - id: GO:0005634
    label: nucleus
  supported_by:
  - reference_id: PMID:20159555
    supporting_text: >-
      members of a subclass of the DNAJB family (particularly DNAJB6b and
      DNAJB8) are superior suppressors of aggregation and toxicity of
      disease-associated polyglutamine proteins. The antiaggregation activity
      is largely independent of the N-terminal Hsp70-interacting J-domain.
      Rather, a C-terminal serine-rich (SSF-SST) region and the C-terminal
      tail are essential.
  - reference_id: PMID:23612975
    supporting_text: >-
      we conclude that the mechanism of DNAJB6 and DNAJB8 is suppression of
      polyQ protein aggregation by directly binding the polyQ tract.
  - reference_id: PMID:21231916
    supporting_text: >-
      Overexpressed chaperones that suppressed polyQ aggregation were found not
      to be able to stimulate luciferase refolding. Inversely, chaperones that
      supported luciferase refolding were poor suppressors of polyQ aggregation.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: PMID:20159555
  title: A DNAJB chaperone subfamily with HDAC-dependent activities suppresses toxic
    protein aggregation.
  findings: []
- id: PMID:21231916
  title: The diverse members of the mammalian HSP70 machine show distinct chaperone-like
    activities.
  findings: []
- id: PMID:21630459
  title: Proteomic characterization of the human sperm nucleus.
  findings: []
- id: PMID:23612975
  title: The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation
    of polyglutamine peptides.
  findings: []
- id: DOI:10.1016/j.str.2024.02.015
  title: DNAJB8 oligomerization is mediated by an aromatic-rich motif that is
    dispensable for substrate activity.
  findings:
    - statement: >-
        AFSSFN (147-152) steric-zipper motif resolved at 0.75 angstrom by MicroED
        as a class 6 steric zipper stabilized by aromatic interactions (F148, F151);
        F151 is a primary driver of full-length DNAJB8 self-assembly.
    - statement: >-
        Engineered monomeric DNAJB8 variants retain substrate binding and
        anti-aggregation function, demonstrating oligomerization is mechanistically
        separable from chaperone activity.
- id: DOI:10.1038/s41467-021-21147-x
  title: Regulatory inter-domain interactions influence Hsp70 recruitment to the
    DnaJB8 chaperone.
  findings:
    - statement: >-
        Intramolecular JD-CTD interaction sequesters the J-domain surface,
        preventing Hsp70 interaction as a reversible regulatory switch controlling
        Hsp70 recruitment.
    - statement: >-
        DNAJB8-Clover forms juxtanuclear puncta in 39.2 +/- 3.1% of cells vs
        0.44 +/- 0.50% for Clover control.
- id: DOI:10.1242/jcs.255596
  title: DNAJB chaperones suppress destabilised protein aggregation via a region
    distinct from that used to inhibit amyloidogenesis.
  findings:
    - statement: >-
        Distinct substrate-binding modes in DNAJB8: serine-rich stretch needed
        for fibrillar/amyloid aggregation suppression but not for FlucDM inclusion
        suppression; a separate CTD TTK-LKS motif is required for amorphous
        inclusion suppression via Hsp70-dependent proteasomal degradation.
- id: DOI:10.1158/0008-5472.CAN-11-3062
  title: HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like
    cells.
  findings:
    - statement: >-
        DNAJB8 preferentially expressed in renal cancer stem-like/cancer-initiating
        cell populations; overexpression increases side population fraction and
        tumor-initiating ability.
- id: DOI:10.1038/s41419-022-04599-x
  title: DNAJB8 in small extracellular vesicles promotes oxaliplatin resistance
    through TP53/MDR1 pathway in colon cancer.
  findings:
    - statement: >-
        DNAJB8 interacts with TP53 and inhibits TP53 ubiquitination, stabilizing
        TP53 and leading to MDR1/P-gp upregulation and increased oxaliplatin
        resistance; sEV-mediated transfer propagates resistance.
- id: DOI:10.1038/s41416-020-1017-1
  title: Development of an artificial antibody specific for HLA/peptide complex
    derived from cancer stem-like cell/cancer-initiating cell antigen DNAJB8.
  findings:
    - statement: >-
        Engineered antibodies targeting HLA-A24/DNAJB8-derived peptide complex
        achieve nanomolar affinity (KD 2.96-5.04 nM) and mediate CDC and
        bispecific antibody-dependent cellular cytotoxicity.